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Chapter 1 
 
Introduction 
 
Rhinovirus 
Rhinovirus (RV) is small, non-enveloped, positive-stranded RNA virus belonging 
to the Picornaviridae family. To date, more than 100 serotypes were identified, and the 
major group serotypes, such as RV14, 16 and 39, bind to intercellular adhesion molecule 
(ICAM)-1 (1), while minor group viruses, for example RV1A, 1B and 2, bind to low 
density lipoprotein family receptors (LDLR) (2). Based on their sequence, RV has been 
further classified into two main phylogenetic species, RV-A and RV-B (3, 4). A novel 
RV-C species has recently been identified (5, 6).  After binding, endocytosis, and 
endosomal acidification, RV releases their viral RNA into cytosol. RV rapidly replicates, 
requiring approximately 8 hours for the full cycle of replication. High mutation rate 
during replication results in distinct genetic diversity.  
 RV has been indicated as the most frequent cause of the common cold. The 
symptoms of RV infection are usually mild in normal healthy persons compared to the 
infection with other respiratory viruses like influenza and respiratory syncytial virus 
(RSV). However, RV infection in patients with chronic respiratory diseases such as 
asthma or chronic obstructive pulmonary disease (COPD) causes severe exacerbations of 
the disease state. Asthma exacerbations are characterized by increased airway 
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inflammation, excessive mucus production, and bronchoconstriction which together 
result in airflow obstruction.  Viral infections are responsible for 80% of asthma 
exacerbations in children and roughly 50% of exacerbations in adults (7, 8).  RV accounts 
for the most virus-induced asthma exacerbations (9) although the specific mechanisms of 
RV triggered asthma exacerbations are not completely known.   
  
Potential role of early-life rhinovirus infection in asthma initiation 
 Asthma is a chronic inflammatory disease characterized by airway inflammation, 
mucus hyperplasia, and airway hyperresponsinvess which together result in airflow 
obstruction (10). Asthma is one of the most common chronic diseases worldwide, 
affecting about 3 million people, with the highest prevalence in westernized countries 
(11).  Results from studies of young children with wheezing have uncovered strong 
associations between both lung function and immune responses in early life and the 
subsequent development of persistent asthma to adulthood (12). On this basis, attention 
has been focused on the origins of asthma in infancy and childhood. 
 Early-life wheezing-associated respiratory tract infections have long been 
considered risk factors for asthma.  Initial attention focused on the potential role of 
respiratory syncytial virus (RSV).  Data from the Tucson Children's Respiratory Study 
showed that RSV lower respiratory tract illness in early childhood was an independent 
risk factor for the subsequent development of wheezing up to age 11 years, but not at age 
13 (13). In Sweden, children hospitalized with RSV bronchiolitis have a greater risk of 
asthma and allergy at ages 7 and 13 (14, 15).  In a St. Louis cohort, about 50% of 
children who required emergency department treatment or hospitalization for RSV 
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bronchiolitis had a diagnosis of asthma at age 3-7 years (16).  
Evidence also exists for an association between early-life rhinovirus (RV) 
infection and asthma.  In Finnish infants hospitalized for respiratory infection-associated 
wheezing, RV was associated with asthma development in contrast to RSV, which was 
negatively associated (17). Data from a birth cohort of high-risk infants from Madison, 
Wisconsin (one parent with respiratory allergies or a history of physician-diagnosed 
asthma) showed that wheezing-associated illness with RV is the most important risk 
factor for asthma development, higher than that of infants with allergen sensitization or 
RSV infection (18, 19). A population-based retrospective analysis of a birth cohort of 
90,000 Tennessee children showed an increased risk of early childhood asthma following 
bronchiolitis during RV-predominant non-winter months vs. RSV-predominant winter 
months (20). Together, these data are consistent with the notion that early-life viral 
infections, including those with RV, perhaps in combination with other factors such as 
genetic background, allergen exposure and microbiome, modulate the immune response, 
increasing the likelihood of childhood asthma development.  
Alternatively, RV infections may simply reveal a pre-existing tendency for 
asthma. For example, further analysis of the Wisconsin birth cohort showed that allergic 
sensitization precedes RV-associated wheeze more often than the converse (21). Also, 
Danish children developing asthma by age seven had a lung function deficit and 
bronchial hyperresponsiveness as neonates  (22) suggesting that asthma precedes RV 
infection. However, none of these studies, which correlate respiratory tract infection, 
airway function and allergen sensitization, provide causal information regarding the 
potential effects of RV infection on asthma development or the underlying mechanisms 
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involved. Such data can only be provided using an animal model (Figure 1-1).  
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Figure 1-1. Possible implications of the clinical association between early-life RV 
infection and later-life asthma development.  RV infection in early life can modulate 
the developing immune response, increasing the likelihood of asthma development. On 
the other hand, wheezing with RV infection may simply reveal a pre-existing tendency 
for asthma.  An improved understanding of immune responses to RV in early life is 
needed to resolve this issue.  
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Neonatal immunity  
Neonates are more vulnerable to infection than adults. Studies have found that 
both innate and adaptive immunity of neonates are qualitatively different from that of 
adults (23, 24). One of the key features of neonatal immunity is a diminished pro-
inflammatory type 1 immune response (including cytokines such as IL-12 and 
interferons), which make them susceptible to viral and microbial infection (25-32). 
Moreover, type 2-polarized immune responses have been observed in neonates. For 
example, mice initially exposed or immunized as neonates showed type 2-biased memory 
responses when re-exposed to the same infection or antigens as adults (33-35). These 
suppressed type 1and enhanced type 2 immune responses in neonates might be attributed 
to several factors including age-related epigenetic changes (36), increased specific 
plasma factors such as adenosine (37), heightened immune tolerance via regulatory T 
cells (38) or CD71+ erythroid cells (39).  After birth, infants undergo a significant 
transition from the sterile in utero environment to a world full of foreign antigens. It has 
been suggested that the decreased type 1 immune response helps neonates to avoid an 
unnecessary pro-inflammatory response when colonized by commensal microorganisms 
in the skin and intestinal tracts (40). However, prolonged maintenance of this type 2-
biased immature immunity and the lack of strong type 1 immune stimuli could lead to the 
development of allergy and asthma, in accord with hygiene hypothesis (41). 
 
Asthma and type 2 immune response 
 Asthma has been long considered as a cluster of differentiation (CD)-4+  T-
helper-2 (Th2)-driven allergic airways disease.  In the presence of allergen, antigen 
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presenting cells (APC) such as dendritic cells and macrophages residing in the peripheral 
tissues process the antigen and present the antigenic peptide to naïve CD4 T cells in the 
lymph nodes. In the presence of pro-allergic cytokines IL-4 and IL-13, or with the 
expression of cell surface molecules such as OX-40L on APC, naïve CD4 T cells 
differentiate into the Th2 cell lineage. Then, CD4+ Th2 cells secrete more type 2 
cytokines, including IL-4, IL-5, and IL-13, as well as granulocyte macrophage colony 
stimulating factor (GM-CSF) (42). Among those cytokines, the role of IL-13 in asthma 
pathogenesis has been highlighted. Transgenic mice overexpressing IL-13 show 
enhanced airway hyperresponsiveness and type 2 cytokine production,  suggesting that 
IL-13 plays a critical role in exacerbating allergic airway inflammation (43).  In humans, 
IL-4, IL-5, and IL-13, have been found in bronchial biopsy specimens from asthmatics 
(44, 45). These type 2 cytokines promotes eosinophil infiltration, mucus secretion (46, 
47) and contribute to overall airway inflammation and airflow obstruction. 
 
TSLP and IL-25 
TSLP, IL-25 and IL-33 are epithelium-derived cytokines which play a role in the 
maturation of Th2 cells via DC activation (48-53). These cytokines also induce the 
activation and IL-13 production from innate immune cells, namely type 2 innate 
lymphoid cells (ILC2s) (54-60), iNKT cells (61-63) and type 2 myeloid cells (64). TSLP 
is an IL-7-like cytokine which exerts its biological activity via a high-affinity TSLPR 
complex that is a heterodimer of the TSLPR chain and IL-7 receptor-α.  Transgenic mice 
that overexpress TSLP in the lungs show an augmented Th2 inflammatory response and 
airway remodeling (goblet cell hyperplasia and subepithelial fibrosis) when challenged 
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with ovalbumin, whereas TSLPR-deficient mice show an attenuated Th2 inflammatory 
response and remodeling (65).  TSLP and IL-25 are secreted from airway epithelial cells 
upon house dust mite challenge, leading to dendritic cell (DC) activation and adaptive 
Th2 response (66).  IL-25/IL-17E is a member of the structurally related IL-17 cytokine 
family which binds to the IL-17B receptor (IL-17BR).  Overabundance of IL-25 leads to 
an allergic phenotype characterized by high levels of IL-4, IL-5, and IL-13, airways 
hyperresponsiveness and enhanced IgE (67, 68), whereas IL-25 deficiency leads to 
reduced Th2 cytokine production (69).  
 Because the airway epithelium is the primary target of respiratory viral infection, 
TSLP, IL-25, IL-33 and their downstream cellular targets are uniquely positioned to play 
a role in viral-induced chronic airways disease. RV16 induces TSLP expression in 
primary human bronchial epithelial cells (53, 70), and RSV and influenza have similar 
effects (71, 72). RV infection in young children is associated with elevated airway TSLP 
levels (73). Immature mice infected with pneumonia virus of mice (PVM), like RSV a 
member of the of the Paramyxoviridae family, show increased lung IL-25 mRNA 
expression (74), and administration of anti-IL-25 decreased PVM-induced lymphocytic 
and eosinophilic airway inflammation (75). IL-17RB
+
 iNKT cells are required for the 
development of RSV-induced airways hyperresponsiveness (76) and IL-25-dependent 
ILC2s have been shown to be required for PVM-induced airways responses in immature 
TLR7 knockout mice (77).  
 Little is known about changes in viral-induced TSLP and IL-25 expression with 
development. However, there is reason to believe that expression of these cytokines 
might be accentuated in newborns and infants.  As noted above, immature animals are 
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more susceptible to viral infection, in part due to impaired IL-12 and IFN production (49-
56). As shown previously with neonatal adenovirus infection (78), baby mice show 
impaired IFN-γ responses to human rhinovirus 1B (RV1B) infection compared to adults, 
as well as reduced levels of IL-12 and TNF-α.  We found that RV-infected immature 6 
day-old mice maintained high levels of viral RNA ≥ 72 h after infection, representing at 
least three rounds of viral replication, in contrast to 8-week-old mature mice in which 
vRNA and titer peak within 24 h after infection (79).  IFN-γ has been shown to inhibit 
double-stranded RNA-induced TSLP production in fibroblasts (80) and keratinocytes 
(81).  Thus, immature animals with relatively impaired IFN responses would be expected 
to express higher levels of TSLP in response to viral infection. 
 
Type 2 innate lymhphoid cells 
Innate lymphoid cells (ILCs) have morphological characteristics similar to those 
of lymphocytes, but they do not express T cell or B cell antigen receptors and lack cell 
surface markers associated with other cell lineages of the immune system.  ILCs express 
CD90 (Thy1 antigen), CD25 (IL-2Rα) and CD127 (IL-7Rα), and their development is 
partially or wholly dependent on the common γ-chain (γc or CD132), IL-7, Notch and the 
transcription factor Id2.  Lineage (Lin)-negative, c-Kit
+
, Sca-1
+
 “natural helper cells” are 
required for IL-13 production and goblet cell hyperplasia during intestinal infection with 
N. brasiliensis (54) and IL-13 production and airways hyperresponsiveness following 
influenza A infection (56). In addition, non-T, non-B, c-kit
+
, IL-17RB
+
, ST2L
+
 
“nuocytes” are responsible for IL-13 production in N. brasiliensis-infected (55) and 
ovalbumin-sensitized and -challenged mice (59).  Lin-, c;Kit
+
, Sca-1
+
, IL-2Rα/CD25+, 
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IL-7Rα/CD127+ “lung natural helper” cells are required and sufficient for IL-13 
production, airways hyperresponsiveness and mucus secretion in papain-treated mice 
(60).  Although there are some differences among natural helper cells, nuocytes and lung 
natural helper cells in terms of their phenotypes and tissue distribution, it has been agreed 
that these cells should all be referred to as type 2 innate lymphoid cells (ILC2 cells). 
ILC2s produce IL-5, IL-9, IL-13, and/or amphiregulin and are dependent on RORα, 
GATA3 and TCF-1 for their development. (82).  
 
Invariant natural killer T cells (iNKTs) 
 iNKT cells, an unusual group of T lymphocytes that recognize glycolipid antigens 
presented by the major histocompatibility complex (MHC) class I-related protein CD1d, 
are also an important source of type 2 cytokines. Cd1d -/- mice do not develop 
ovalbumin-induced airways hyperresponsiveness (83) and α-GalCer, a marine sponge 
glycolipid antigen that specifically activates CD1d-restricted iNKT cells, is sufficient to 
induce IL-4/13-dependent airways hyperresponsiveness (84).  iNKT cells express TSLPR 
and IL-7R α-chain, preferentially increase IL-13 production upon TSLP stimulation, and 
are required for development of ovalbumin-induced  airway hyperreactivity in transgenic 
mice expressing TSLP under the control of the surfactant protein C promoter (61). Other 
iNKT cells express IL-17RB, produce large amounts of type 2 cytokines upon IL-25 
stimulation, and are required for IL-25-mediated airways hyperresponsiveness (62).  
 
Animal models of RV infection   
Species differences in ICAM-1 represent the main challenge in developing an 
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animal model of a human major group RV infection. Recently, we (85) and others (86) 
showed that minor group serotype RV1B, which binds proteins of the low-density 
lipoprotein receptor family, infects C57BL/6 and Balb/c mice, thereby providing an 
animal model to study RV-induced airway inflammation. We reported evidence of human 
RV1B replication in mouse lungs as follows: 1) the presence of negative-strand viral 
RNA in the lungs of inoculated mice, 2) the transmissibility of RV infection from the 
lung homogenates of inoculated mice to cultured HeLa cells, and 3) the induction of a 
robust lung IFN response (85).  Replication-deficient UV-irradiated virus elicited none of 
these effects. RV infection also caused a moderate increase in airway resistance to 
methacholine, suggesting a role for RV-induced airway inflammation in airway hyper-
reactivity.  
The airway response to the major group virus RV16 was recently studied using a 
transgenic mouse expressing humanized Intercellular Adhesion Molecule 1 (ICAM-1) 
(86). The effects induced by RV16 were indistinguishable from those induced by RV1B. 
Studies indicate that major and minor group viruses induce nearly identical patterns of 
gene expression in cultured airway epithelial cells (87). Furthermore, recent analysis of 
all known HRV genomes has revealed that HRV1 and HRV16 are highly homologous 
and respond similarly to small-molecule antiviral compounds (88). Thus, the distinction 
between at least some major and minor group strains may not be clinically relevant. 
Therefore, we believe that mouse models of human RV1B infection hold promise for the 
study of RV-induced exacerbations of chronic airway diseases, such as asthma.   
 
Significance 
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The onset of asthma is highly influenced by gene-environment interactions during 
the neonatal period, but the factors involved are not fully identified (41, 89). Recent 
studies suggest a possible role for the common cold virus, rhinovirus (RV), in the 
pathogenesis of asthma. Epidemiologic studies in children with a family history of 
asthma now show a strong association between the development of childhood asthma and 
wheezing-associated infections with rhinovirus (18, 19). This association with asthma 
was stronger than those with RSV infection or allergic sensitization (19).  
Nevertheless, the question of whether rhinoviral infections can cause asthma is 
still controversial. While it is possible that early-life RV infection promotes asthma by 
modulating immune system that is under development, wheezing-associated with RV 
may simply be a marker of pre-existing airways disease. An improved understanding of 
immune responses to RV in early-life is needed to resolve this issue. 
Recent studies have found that the immunity of newborns is qualitatively different 
from that of adults. When faced with an infection, neonatal animals are refractory to so-
called type 1 pro-inflammatory responses and permissive to type 2 allergic responses (33, 
90). It is therefore possible that early-life RV infection promotes allergic asthma by 
augmenting or maintaining this immature response. 
Thus, we attempted to generate a neonatal RV infection model to test the role of 
early-life RV infection in the development of asthma.  We sought to examine this issue 
with the following specific aims (Figure 1-2):  
1. Determine the role of IL-25 and ILC2s in RV-induced asthma phenotype 
development in neonatal mice (Chapter 2); 
2. Determine the contribution of TSLP and ILC2s in RV-induced asthma phenotype 
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development in neonatal mice (Chapter 3); 
3. Determine the role of IL-4R signaling in RV-induced asthma exacerbation 
(Chapter 4).  
This research is significant because it shows a direct casual role of RV infection 
in the inception of an asthma-like phenotype. Completion of subsequent dissertation work 
may facilitate the development of effective clinical methods for prevention and treatment 
of asthma.  
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Figure 1-2. Model of neonatal RV-induced mucous metaplasia and airways 
hyperresponsiveness.  RV infection of the airway epithelium induces expression of 
TSLP (Chapter 1) and IL-25 (Chapter 2), stimulating expansion and/or activation of type 
2 cytokine-producing innate immune cells (Chapter 1-3). 
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Chapter 2 
 
 
Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness 
via IL-25 and ILC2s   
 
Summary 
Early-life rhinovirus (RV) infection has been linked to asthma development in 
high risk infants and children. Nevertheless, the role of RV infection in the initiation of 
asthma is still controversial.  We hypothesized that, in contrast to infection of mature 
BALB/c mice, early-life infection with RV promotes an IL-25-driven type 2 response 
which causes persistent mucous metaplasia and airway hyperresponsiveness (AHR). 
Compared to mature mice, RV infection in neonatal mice increased lung IL-13 and IL-25 
production whereas IFN-γ, IL-12p40 and TNF-α expression were suppressed.  We also 
found that the population of IL-13-secreting type 2 innate lymphoid cells (ILC2s) was 
expanded with RV infection in neonatal but not in mature mice.  ILC2 cells were the 
major cell type secreting IL-13 in neonatal mice.  Finally, administration of an anti-IL-25 
neutralizing antibody attenuated ILC2 expansion, mucous hypersecretion and airways 
responsiveness.  These findings suggest that early-life viral infection could contribute to 
asthma development by provoking age-dependent, IL-25-driven type 2 immune 
responses. 
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Introduction 
The precise mechanisms of asthma development are not fully understood.  
Initiation of asthma is highly associated with enhanced type 2 and reduced type 1 
immunological responses which are in turn influenced by allergen exposure, respiratory 
infection and genetic susceptibility. Early-life exposures to immune-modulating factors in 
infancy may be particularly important in determining the vulnerability to lifelong asthma 
development.  
Studies have found that the immature immune system is qualitatively different 
from that of adult, refractory to type 1 and permissive to type 2 responses. In contrast to 
mature T cells, human cord blood T cells demonstrate a permissive chromatin 
architecture at the IL-13 proximal promoter, favoring transcription (1).  Murine neonatal 
CD4+ T cells harbor IL-4/IL-13 regulatory elements which are epigenetically modified to 
favor type 2 responses (2). With antigen challenge, secondary exposure to antigen causes 
IL-4-dependent depletion of T helper type 1 (Th1) cells in neonatal but not adult mice (3)  
Secretion of the type 1 cytokine IL-12 is suppressed in neonatal dendritic cells, thereby 
inhibiting Th1 cell differentiation (4-6).  Finally, the innate type 1 response to TLR 
stimulation is significantly diminished in neonatal monocytes (7-9).  Thus, in early life, 
type 2-biased neonatal adaptive and innate immune responses could provide a favorable 
environment for asthma development, particularly when maintained by appropriate 
stimuli. 
Wheezing-associated acute respiratory viral infections in infancy, particularly 
those caused by respiratory syncytial virus (RSV), have long been considered risk factors 
for asthma (10, 11). However, recent studies suggest a possible role for the common cold 
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virus, rhinovirus (RV). Epidemiologic studies now show a strong association between 
early-life RV infection and the development of asthma in infants and children with a 
family history of asthma (12).  In Finnish infants hospitalized for respiratory infection-
associated wheezing, RV was associated with asthma development in contrast to RSV, 
which was negatively associated (13).  Retrospective analysis of a birth cohort of 90,000 
children showed an increased risk of early childhood asthma following bronchiolitis 
during RV-predominant non-winter months vs. RSV-predominant winter months (14). 
However, while it is possible that early-life RV infection promotes asthma by 
maintaining an immature type 2 immune response, wheezing associated with RV may 
simply be a marker of pre-existing airways disease. To examine this question, we tested 
the effects of RV infection in neonatal and mature BALB/c mice and found that, in 
contrast to adults, neonatal infection induced type 2 cytokine expression, airway 
hyperresponsiveness and mucous metaplasia (15). Nevertheless, the mechanisms by 
which RV infection may lead to chronic airways disease, including the roles of 
development, remain unclear. 
Interleukin 25 (IL-25/IL-17E), a cytokine belonging to IL-17 family, is a potent 
inducer of type 2 immunity (16).  Systemic injection of IL-25 induces eosinophilia, 
mucus hyperplasia and type 2 cytokines such as IL-4, IL-5, and IL-13 (16).  
Overexpression of IL-25 in epithelial cells induces goblet cell hyperplasia and a type 2 
immune response (17), and intranasal IL-25 administration provokes airways 
hyperresponsiveness (18).  Moreover, blocking of IL-25 reduces airways responsiveness 
in a mouse model of allergic asthma (19).  Recent studies have found that, upon IL-25 
stimulation, lineage-negative lymphoid cells expressing the IL-25 receptor IL-17RB 
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secrete the type 2 cytokines IL-5 and IL-13, promoting a type 2 immune response (20-
24). These cells, originally termed natural helper cells, nuocytes, innate helper cells or 
type 2 multipotent progenitor cells, are now referred to as type 2 innate lymphoid cells 
(ILC2s) (25).  On this basis, we hypothesized that early-life infection with RV promotes 
an IL-25-driven ILC2-mediated type 2 response, leading to persistent mucous metaplasia 
and airway hyperresponsiveness.  
 
Methods 
Generation of RV.  
RV1B (ATCC, Manassas, VA) were grown in HeLa cells, concentrated and 
partially purified (26).  Similarly concentrated and purified HeLa cell lysates were used 
for sham infection. Viral titer was measured by fifty percent tissue culture infectivity 
doses (TCID50) using the Spearman-Karber method (27) or by plaque assay (28).   
 
RV infection.  
Experiments were approved by the University of Michigan Institutional Animal 
Care and Use Committee.   BALB/c mice (Jackson Laboratories, Bar Harbor, ME) were 
inoculated through the intranasal route under Forane anesthesia with RV1B (1x10
8
 
PFU/ml) or sham HeLa cell lysates. To 5-24 day-old mice, 20 μl of RV1B (2x106 PFU) 
or an equal volume of sham was given. To 21 day-old mice, 30 μl of RV1B (3x106 PFU) 
or sham was given. To eight week-old mice, 50 μl of RV1B (5x106 PFU) or sham was 
administered. 
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Anti-IL-25 neutralizing antibody treatment.   
Six-day old neonatal mice were treated with either 100 μg of neutralizing 
antibody to IL-25 (clone 35B, Biolegend, San Diego, CA) or isotype control (rat, IgG1κ) 
intraperitoneally at days 0, 7 and 14 of infection. Mice were sacrificed 3-4 weeks after 
infection for analysis. 
  
Flow cytometric analysis.  
Lungs were perfused with PBS containing EDTA, minced and digested in 
collagenase IV. Cells were filtered and washed with RBC lysis buffer, and dead cells 
were stained with Pac-Orange Live/Dead fixable dead staining dye (Invitrogen, Carlsbad, 
CA). Cells were then stained with FITC-conjugated antibodies for lineage markers 
(CD3ε, TCRβ, B220/CD45R, Ter-119, Gr-1/Ly-6G/Ly-6C, CD11b, CD11c, F4/80 and 
FcεRIα, from Biolegend), anti-CD25-PerCP-Cy5.5 (Biolegend), anti-CD127-PE-Cy5 
(eBioscience, San Diego, CA), anti-c-kit/CD117-APC (eBioscience), anti-sca-1-PE-Cy7 
(eBioscience), anti-T1/ST2-PE (R&D Systems, Minneapolis, MN) and anti-IL-17RB 
(R&D Systems) conjugated with AF750.  Cells were fixed, subjected to flow cytometry 
and analyzed on a FACSAria II (BD Biosciences, San Jose, CA). Data were collected 
using FACSDiva software (BD Biosciences) and analyzed using  FlowJo software.                       
   
Assessment of airway responsiveness.  
Airway cholinergic responsiveness was assessed by measuring changes in total 
respiratory system resistance in response to increasing doses of nebulized methacholine 
(15).  Mice were anesthetized with sodium pentobarbital (50 mg/kg mouse, 
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intraperitoneal injection) and a tracheostomy performed. Mechanical ventilation was 
conducted and total respiratory system measured using a Buxco FinePointe operating 
system (Buxco, Wilmington, NC). Airway responsiveness was assessed by measuring 
changes in resistance in response to increasing doses of nebulized methacholine. 
Statistical analysis was performed using two-way ANOVA with repeated measures, 
employing Graph Pad Prism 6.0 software program. 
 
Histology and immunohistochemistry.   
Lungs were collected and fixed with 10% formaldehyde and paraffin embedded. 
Blocks were sectioned at 500-μm intervals at a thickness of 5 μm, and each section was 
deparaffinized and hydrated. After antigen demasking and permeabilization, sections 
were incubated with Alexa Fluor (AF)-488-conjugated rabbit anti-mouse IL-25/IL-17E 
(Millipore, Billerica, MA), guinea pig antiserum against HRV1B (ATCC), or AF-
conjugated isotype control IgGs. Antiserum was partially purified by incubation with 
nitrocellulose-bound HeLa cell proteins and passing through an affinity resin containing 
nondenatured mouse lung protein, as described previously (29).  Repurified antibody was 
directly conjugated to AF594. The control used was AF594-conjugated guinea pig 
antiserum. Nuclei were stained with 4′,6-diamidino-2-phenylindole. Images were 
visualized using a Zeiss Axioplan microscope equipped with an ApoTome and digital 
AxioCamMR charge-coupled device camera. To visualize mucus, deparaffinized sections 
were stained with periodic acid-Schiff (Sigma-Aldrich, St. Louis, MO).  
 
Intracellular cytokine analysis with flow cytometry.  
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For analysis of intracellular IL-13 production, freshly isolated aliquots of lung 
mince were stimulated for 5 h with cell stimulation cocktail (PMA (40.5 uM), Ionomycin 
(670 uM), Brefeldin A (5.3 mM), Monensin (1 mM), eBioscience, San Diego, CA). Cells 
were then stained for live/dead and surface markers, fixed, permeabilized and incubated 
with anti-mouse IL-13 (eBioscience, San Diego, CA). Cells were fixed and analyzed 
utilizing the FACSAria II (BD Biosciences, San Diego, CA). 
 
Fluorescence-activated cell sorting of ILC2s and treatment.  
After staining for lineage markers, lineage-negative CD25 and CD127 double-
positive ILC2s or lineage-negative CD25 and CD127 double-negative cells were sorted at 
9000 cells/200 μl concentration in each well of 96 well plates and stimulated with 
different factors. To visualize ILC2s, cells were stained with Diff-Quick (Dade Behring, 
Newark, DE). Cells were stimulated with media, IL-25 (20 ng/ml), IL-2 (50 ng/ml) + IL-
25 (20 ng/ml) or PMA + Ionomycin for 3 days. IL-13 protein concentration was 
measured by ELISA. 
 
Measurement of IL-13 and IL-25.   
IL-13 and IL-25 concentrations were measured with ELISA (eBioscience, San 
Diego, CA).  The amount of IL-25 per lung weight was calculated by multiplying the 
concentration by the volume of lung homogenate divided by the weight of lungs.  
   
Real-time quantitative PCR.   
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Lung RNA was extracted with Trizol method (Invitrogen, Carlsbad, CA) with the 
combination of on-column digestion of genomic DNA (Qiagen, Valencia, CA). cDNA 
was synthesized from 1 μg of RNA and subjected to quantitative real-time PCR using 
specific mRNA primers for IL-4, IL-5, IL-13, IFN-γ, IL-12p40, TNF-α, Muc5ac, Muc5b, 
Gob5 and IL-17RB. The sequences of specific primers are provided (Table 2-1).The level 
of gene expression was normalized to mRNA of GAPDH.  
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TABLE 2-1.  Sequence of primers for quantitative PCR. 
     
Gene 
name Forward primer (5’->3’) Reverse primer (3’->5’) 
GAPDH GTC GGT GTG AAC GGA TTT G GTC GTT GAT GGC AAC AAT CTC 
Gob5 CTG TCT TCC TCT TGA TCC TCC A CGT GGT CTA TGG CGA TGA CG 
IFN-g TGG CTG TTT CTG GCT GTT AC TCC ACA TCT ATG CCA CTT GAG TT 
IL-12p40 CTC CTG GTT TGC CAT CGT TT GGG AGT CCA GTC CAC CTC TA 
IL-13 CCT GGC TCT TGC TTG CGT GGT CTT GTG TGA TGT TGC TCA 
IL-17RB ACC TTC CGG CGG CAA ATG GAC GCA TTG GGG ATG TTA TGG GCG CT 
IL-25 ACA GGG ACT TGA ATC GGG TC TGG TAA AGT GGG ACG GAG TTG 
IL-33 GGC TGC ATG CCA AGG ACA AGG AAG GCC TGT TCC GGA GGC GA 
IL-4 GGT CTC AAC CCC CAG CTA GT GCC GAT GAT CTC TCT CAA GTG AT 
IL-5 CTC TGT TGA CAA GCA ATG AGA CG TCT TCA GTA TGT CTA GCC CCT G 
Mub5b GAG CAG TGG CTA TGT GAA AAT CAG CAG GGC GCT GTC TTC TTC AT 
Muc5ac AAA GAC ACC AGT AGT CAC TCA GCA A CTG GGA AGT CAG TGT CAA ACC 
TNF-a ATG CAC CAC CAT CAA GGA CTC AA ACC ACT CTC CCT TTG CAG AAC TC 
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Results 
Compared to adult mice, RV infection of neonatal mice provokes an enhanced type 2 
immune response and attenuated type 1 response.   
We infected 6 day-old and 8 week-old mice with RV1B and analyzed cytokine 
gene expression.  Unlike mature mice, RV infection of neonatal mice increased 
expression of the type 2 cytokines IL-13, IL-4 and IL-5 immediately post-infection, with 
slightly different kinetics (Figure 2-1A).  In contrast, induction of type 1 cytokines IFN- 
and IL-12p40 gene was blunted in neonatal mice, whereas expression was increased in 
mature mice (Figure 2-1B). Compared to sham infection, TNF-α gene expression was 
significantly increased in both neonates and adults after RV infection, but induction was 
significantly less in neonatal mice.  Consistent with the attenuated type 1 response, viral 
replication and load tended to be greater 3-7 days after inoculation in neonatal mice 
compared to adults (Figure 2-2).  We performed additional studies examining the age-
dependency of RV-induced cytokine responses.  RV-induced IL-13 expression was 
increased, and IFN- expression decreased up to 8 days of age (Figure 2-1C).  These 
results show that early-life RV infection elicits exaggerated type 2 responses and 
mitigated type 1 responses. 
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Figure 2-1. Cytokine expression after RV infection.  A and B, Six-day-old and eight-
week-old mice were inoculated with sham or RV (n=4-8 sham, n=5-14 RV) and lung 
mRNA measured 1-7 days later. *P<0.05 compared to sham (unpaired t-test). C and D, 
Mice of different ages (n=3-10/group) were inoculated with sham or RV and mRNA 
expression measured one day later.  *P<0.05 versus sham (unpaired t-test).  
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Figure 2-2. Viral copy number in RV-infected neonatal and adult mice.  Six-day-old 
and eight week-old mice were inoculated with sham or RV intranasally.  At specified 
times, lungs were harvested for analysis. Viral copy number was analyzed by qPCR.  
Shown are individual data, medians and interquartile range for each time point.  
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Infection of neonatal mice with RV provokes long-term mucus metaplasia and airways 
hyperresponsiveness.  
Neonatal RV infection led to persistent asthma-like pathophysiological changes 
including IL-13 expression, mucous metaplasia and airways hyperresponsiveness (Figure 
2-3A-C).  The mucus-related genes Muc5ac, Muc5b and Gob5 were increased with 
neonatal but not adult RV infection (Figure 2-3D).  Induction of Muc5ac and Gob5 was 
maintained after 8 weeks of infection (Figure 2-4).  We also found that IL-17RB gene 
expression was increased (Figure 2-3E), suggesting a possible role for IL-25 in 
promoting the type 2 immune response.   
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Figure 2-3. Mucous metaplasia and airway hyperresponsiveness after neonatal RV 
infection. A, Lung IL-13 from six day-old mice. *P<0.05 versus sham (unpaired t-test). 
B, PAS-stained lung sections prepared 3 weeks after inoculation of six day-old and eight 
week-old mice (magnification, 100X; bar. 200 μm).  C, Airway responsiveness four 
weeks after inoculation of neonatal mice (n=4/group). * P<0.05 versus sham (two-way 
ANOVA).  D and E, Lung mRNA expression three weeks after inoculation. *P<0.05 
versus sham (unpaired t-test).  
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Figure 2-4. Persistent expression of mucus-related gene expression in 8 week-old 
mice infected with RV. Gene expression of Muc5ac, Muc5b, Gob5, and IL-13 was 
analyzed with quantitative PCR. * P < 0.05 versus sham (unpaired t-test).  
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Epithelial IL-25 is increased with neonatal RV infection.   
We next asked whether IL-25 expression is increased following neonatal RV 
infection and differentially regulated with age.  Similar to the induction of type 2 
cytokines, IL-25 mRNA expression was increased in RV-infected neonatal mice (6-day-
old) but not mature mice (8-10 weeks old) (Figure 2-5A). IL-25 protein production was 
induced with RV infection in neonates but not adults (Figure 2-5B).  Expression of IL-33 
did not change with infection (Figure 2-6). Additional studies examining the age-
dependency of RV-induced IL-25 expression showed significant induction only in mice 
younger than 6 days-old (Figure 2-5C).  UV-irradiated, replication-deficient virus did not 
generate a response (data not shown). We also asked whether viral dosage affects the 
neonatal type 2 cytokine response. Low-dose RV significantly increased IL-25 but not 
IFN-γ mRNA 24 h after infection (Figure 2-7). These results show that RV-induced type 
2 cytokine production in neonates is not dose-dependent.  Lung immunofluorescent 
staining showed that RV-infected epithelial cells were the major source of IL-25 (Figure 
2-5D). Lungs of RV-infected mature mice showed minimal IL-25.   
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Figure 2-5. Lung IL-25 after RV infection. A, Six-day-old and eight-week-old mice 
were inoculated with sham or RV (n=4-7/group) and mRNA measured 1-7 days after 
infection. *P<0.05 versus sham (unpaired t-test). B, IL-25 protein. *P≤0.05 versus sham 
(one-way ANOVA). C, Mice were inoculated at different ages (n = 3-10/group) and 
mRNA measured one day after treatment.  *P<0.05 versus sham (unpaired t-test). D, Two 
days after infection, lungs were stained for IL-25 (green), RV (red) and nuclei (DAPI, 
black). (Bar, 200 μm; magnification, 200X).  
  
  
 41 
 
 
 
Figure 2-6. Effect of RV infection on the expression of IL-33.  Six-day-old neonatal 
BALB/c mice and eight-week-old mature mice were inoculated with sham or RV. Whole 
lung gene expression of IL-33 was measured 1-7 days after infection with quantitative 
PCR.  *P < 0.01 versus sham (unpaired t-test).   
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 Figure 2-7. Effect of low-dosage RV infection in the induction of IL-25 and IFN-γ. 
Six-day-old neonatal BALB/c mice were inoculated with sham, or RV (normal dosage), 
or RV (10-fold lower dosage). Whole lung gene expression of IL-25 and IFN-γ mRNA 
was measured one day after infection with quantitative PCR.  *P < 0.05 versus sham 
(unpaired t-test).  
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RV infection of neonatal but not mature mice expands the population of IL-17RB-
expressing ILC2s.  
We collected lungs of neonates and adults two weeks after infection and analyzed 
ILC2s using flow cytometry.  We gated on small cells, live cells and lineage-negative 
cells using mixture of hematopoietic lineage markers (CD3ε, TCRβ, B220, Ter-119, Gr-
1, CD11b, CD11c, F4/80, FcεRIα) (Figure 2-8A). Compared to adults, neonatal mice had 
nearly 2-fold more lineage-negative cells (Figure 2-9).  After gating on the lineage-
negative population, a discrete population of CD25 and CD127 double-positive ILC2s 
was found (Figure 2-8A-B).  The basal level of Lin-negative, CD25, CD127 double-
positive cells in adult mice was comparable to the previous findings in C57BL/6 mice 
(30).  Following RV infection, ILC2s were increased in neonates but not in adults, both in 
percentage and number.  Further analysis showed that Lin-negative, CD25, CD127 
double-positive cells express c-kit (CD117), sca-1, IL-17RB, and ST2L (Figure 2-8C), 
suggesting that they are more closely related to lung natural helper cells than nuocytes, 
innate helper cells or type 2 multipotent progenitor cells, which are heterogeneous in c-kit 
or CD127 expression (22, 24, 31).  ILC2s were increased as early as one day after 
infection and maintained three weeks after infection (Figure 2-8D). Taken together, these 
results suggest that, following neonatal RV infection, the population of lung ILC2s is 
expanded in neonates, possibly through the induction of IL-25. 
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Figure 2-8. Lung lineage-, CD25+, CD127+ ILC2s. A, Six day-old and eight week-old 
mice were inoculated with sham or RV and live ILC2s identified fourteen days later. B, 
Percentage (upper panel) and total (lower panel) ILC2s for each group. *P<0.05 versus 
sham, †P<0.05 versus mature mice (unpaired t-test).  C, C-kit/CD117, Sca-1, T1/ST2 and 
IL-17RB expression in ILC2s from sham- (black, dotted) and RV-treated mice (red, 
solid).  (Isotype control is grey, filled). D, ILC2 time course after neonatal infection (n = 
3-6/group). *P<0.05 versus sham (unpaired t-test). 
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Figure 2-9. Lineage-negative cells in immature and mature mice. Six-day-old 
neonatal BALB/c mice and eight-week-old mature mice were inoculated with sham or 
RV. Lungs were collected 14 days after infection.  Cell suspensions were stained with a 
cocktail of lineage antibodies (CD3ε, TCRβ, B220/CD45R, Ter-119, Gr-1/Ly-6G/Ly-6C, 
CD11b, CD11c, F4/80, and FcεRIα) and subjected to flow cytometry. The percentage of 
lineage-negative live cells was calculated. †P < 0.05 versus neonates (unpaired t-test). 
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ILC2s are a major IL-13-producing cell in RV-infected neonatal mice.   
We asked whether Lin-negative CD25, CD127 double-positive ILC2 cells 
produce IL-13 after RV infection.  First, we analyzed the role of T cells utilizing flow 
cytometric analysis.  Lung samples were collected two weeks after infection and 
stimulated with phorbol 12-myristate 13-acetate, ionomycin, brefeldin A and monensin. 
The main population of IL-13-producing cells was TCRβ-negative (Figure 2-10A).  After 
RV stimulation, the number of IL-13-secreting TCRβ-negative cells was approximately 
18-fold higher than the number of IL-13-secreting TCRβ-positive cells.  To determine if 
ILC2s produced IL-13, lineage-positive and -negative cell populations were stimulated as 
above. The major IL-13-secreting cells were lineage negative (Figure 2-10B).  Among 
lineage-negative cells, CD25, CD127 double-positive cells contained a high IL-13-
producing population (Figure 2-10C) suggesting that ILC2s are a major source of IL-13 
in the lungs of RV-infected neonatal mice.  To further examine the capacity of these cells 
to produce IL-13, we sorted Lin-negative CD25, CD127 double-positive cells and CD25, 
CD127 double-negative cells (Figure 2-11).  Double positive cells expressed c-kit and 
sca-1, whereas double-negative cells were negative for both markers (Figure 2-10D).  
Similar to other ILC2s, double-positive cells were small cells with circular nuclei and 
scanty cytoplasm (Figure 2-10E) (20, 32).  Stimulation with IL-25 and IL-2 or PMA and 
ionomycin induced large amounts of IL-13 (Figure 2-10F).  These results show that an 
expanded population of ILC2s is the major source of IL-13 in RV-infected neonatal mice 
and likely contribute to the observed asthma-like phenotype.   
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Figure 2-10. IL-13 producing cells. A, Percentages of IL-13+, TCRβ- and TCRβ+ cells 
two weeks after neonatal sham or RV. *P<0.05 versus sham, †P<0.05 versus TCRβ- cells 
(unpaired t-test). B and C, Percentages of lineage+ and lineage- IL-13+ cells (B).  
Percentages of lineage- IL-13+, CD127+ and CD25+ cells (C). D-F, Eight days after 
infection, Lin- CD25+ CD127+ double-positive (DP) and CD25- CD127- double-
negative (DN) ILC2s were characterized for c-kit and Sca-1 (D). Image of ILC2 (E). IL-
13 production by stimulated DP and DN cells (F). 
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Figure 2-11. Gating strategy for sorting ILC2s. Six-day-old neonatal BALB/c mice 
were infected with RV.  After 8 days, lungs were processed for cell sorting.  To sort 
ILC2s, low FSC, low SSC, DAPI-negative live cells were gated and incubated with 
lineage cocktail antibodies (CD3ε, TCRβ, B220/CD45R, Ter-119, Gr-1/Ly-6G/Ly-6C, 
CD11b, CD11c, F4/80, and FcεRIα).  Finally, CD25 and CD127 double positive cells 
were identified.   
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IL-25 mediates the development of mucus metaplasia and airways hyperresponsiveness in 
RV-infected neonatal mice.   
To test whether IL-25 is required for the development of an asthma-like 
phenotype, we treated RV-infected neonatal mice with a neutralizing antibody against IL-
25 (Figure 2-12A).  Treatment with anti-IL-25 reduced mucus metaplasia (Figure 2-12B). 
The mucus-related genes Muc5ac, Muc5b, Gob5 decreased with anti-IL-25 treatment 
(Figure 2-12C).  Anti-IL-25 blocked the development of airways hyperresponsiveness 
(Figure 2-12D).  Finally, anti-IL-25 decreased the expansion of ILC2s in RV-infected 
neonates (Figure 2-12E), suggesting that ILC2 expansion is dependent on IL-25. These 
results show that IL-25 plays a key role in the development of mucous metaplasia and 
airways hyperresponsiveness in RV-infected neonatal mice, at least in part by increasing 
the number of ILC2s. 
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Figure 2-12. Effect of IL-25 neutralization on RV-infected neonatal mice. A, Protocol 
for anti-IL-25 treatment. B, Three weeks after inoculation, lungs were harvested and 
stained with PAS. Bar, 100 μm.  C, Lung mRNA expression (n = 4-10/group). *P<0.05 
versus sham, †P<0.05 versus RV+IgG (unpaired t-test). D, Airway resistance four weeks 
after RV infection and antibody treatment (n = 4-5 in each group). *P<0.05 versus 
RV+IgG (two-way ANOVA). E, Lineage-negative CD25+ CD127+ ILC2s four weeks 
after infection (top). Group percentages of live ILC2s (n = 3-8/group, bottom). *P<0.05 
versus sham, †P<0.05 versus RV+IgG (unpaired t-test).   
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Discussion  
In this study, we showed that infection of mice with rhinovirus induces an age-
dependent type 2 immune response in the airways.  Neonatal RV infection, but not adult 
infection, increased expression of IL-13 and IL-25.  In contrast, induction of the type 1 
cytokines IFN-γ, IL-12 p40 and TNF-α was diminished in neonates compared to adults.  
The increase in IL-25 production in neonatal mice was associated with long-term 
expansion of IL-25-responsive ILC2s in the lungs.  Further, ILC2s were a significant 
source of IL-13 after RV infection.  Finally, RV-induced mucous cell metaplasia and 
airways hyperresponsiveness were attenuated by anti-IL-25.  Together, these studies 
indicate that RV induces an age-dependent asthma-like phenotype which is driven by IL-
25 and ILC2s.  These studies provide a mechanism by which viral infection in early-life 
could lead to persistent type 2 immune responses and asthma development.  
The immature immune system is qualitatively different from that of adult, 
refractory to type 1 and permissive to type 2 responses (1-9).  In our experiments, RV-
induced IL-25 was regulated in an age-dependent manner and required for the 
development of mucous metaplasia and airways hyperresponsiveness.  IL-25 appeared to 
be produced by RV-infected epithelial cells, though uninfected cells, including 
submucosal cells, may also have been involved.  To our knowledge, this is the first report 
showing a developmental difference in the IL-25 response.  Considering the epigenetic 
modification favoring type 2 cytokine induction in T cells (2), it is possible that the 
regulatory region of IL-25 is also epigenetically favored transcription in neonates 
compared to adults. Alternatively, blunted induction of type 1 cytokine IFN- in RV-
infected neonates could be permissive for IL-25 induction.  In NK cell-deficient mice, 
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RSV infection leads to an exaggerated IL-25 response which is blocked by recombinant 
IFN- treatment, consistent with the notion that IFN-γ blocks IL-25 expression (33). 
Finally, it is possible that neonates experienced a greater total IL-25 response based on a 
higher viral load 3-7 days after inoculation.  However, treatment of neonatal mice with 
low-dose RV also induced lung IL-25 expression, and NK cell-deficient mice with 
exaggerated IL-25 production and attenuated IFN-γ responses have similar viral loads as 
wild-type mice (33), suggesting the primacy of IFN regulation.   
The cytokine IL-33 has also been associated with development of lung ILC2s and 
type 2 cytokine responses in mice
 
(30). However, IL-33 was not increased with RV 
infection.  Thymic stromal lymphopoietin (TSLP) has also been shown to expand skin 
ILC2s in mice (34).  RV16 infection increases TSLP expression in human airway 
epithelial cells (35).  It is therefore conceivable that TSLP plays a role in RV-induced 
ILC2 expansion.  
 We have previously shown that this IL-13 induction is required for the 
development of RV-induced mucous metaplasia and airways hyperresponsiveness in 
neonatal mice (15).  Persistent induction of IL-13-driven changes in airway inflammation 
and function following viral infection were first reported in Sendai-infected C57BL/6J 
mature mice (36). Subsequently, persistent IL-13 production has been noted following 
neonatal infection by RSV, pneumonia virus of mice (PVM) and influenza exposure (37-
39).  In the case of mature Sendai-infected mice, IL-13 was secreted by a combination of 
M2-polarized macrophages and invariant NKT cells (36).  In the present study, the major 
cells persistently secreting IL-13 were lineage-negative, CD25, CD127 double-positive 
ILC2s. These cells expressed c-kit, Sca-1, ST2, and IL-17RB, closely resembling lung 
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natural helper cells and dissimilar from nuocytes, innate helper cells or type 2 multipotent 
progenitor cells (21-24).. Induction of ILC2s with viral infection has previously been 
shown following in mature mice with influenza virus  (40).  Following H1N1 infection, 
ILC2s restored gas exchange and helped tissue repair by secreting amphiregulin.
,
 After 
H3N1 infection, ILC2s induced IL-13-mediated airway hyperreactivity (41).   Finally, an 
acute increase in ILC2s was recently shown in neonatal TLR7 null mice with a severe 
PVM infection (42).  However, IL-13 production by ILC2s was not assessed, and virus-
induced airway inflammation and airway hyperreactivity was dependent on memory 
CD4+ T cells.  Our experiments extend previous reports in the following respects.  First, 
we found for the first time that ILC2s are expanded following infection with RV, perhaps 
the most common infection of humans.  Second, we established that ILC2s make IL-13 in 
response to viral infection in neonatal animals.  Third, we found a developmental 
difference in the ILC2 response between neonates and adults (see above). This difference 
was based on RV-induced production of ILC2-activating cytokines such as IL-25, rather 
than the infection itself.  Fourth, following neonatal RV infection, IL-13 secretion and 
ILC2 expansion were long-lived, at least 21 days after infection.  It is therefore 
conceivable that ILC2s could produce type 2 cytokines for extended periods, perhaps in 
response to subsequent infection or allergen exposure.  Finally, we showed for the first 
time that, in addition to IL-33, IL-25 is required for ILC2 expansion following viral 
infection.   
 Our finding that RV infection elicits a significant ILC2 response in immature but 
not mature mice, one which is based on the age-dependent expression of IL-25 and other 
cytokines, suggests that it is the stage of development, rather than the specific virus, that 
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drives establishment of the asthma-like phenotype.  Accordingly, it is possible that other 
early-life viral infections also induce mucous metaplasia and airways responsiveness 
through the early expansion of the ILC2 cells.  As noted above, neonatal infection by 
RSV, PVM and influenza have been shown to induce a persistent asthma-like phenotype 
in mice (37-39).  IL-25 production has been noted following neonatal infection with RSV 
(38).  Recently, neonatal PVM infection of TLR7
-/-
 mice showed an IFN-low, IL-25-high 
cytokine response similar to that we observed, which was associated with recruitment of 
ILC2 cells (42). In humans, early-life infection with RV (13, 14, 43) and RSV (10, 11) 
have each been associated with asthma development.   
The association between respiratory viral infection and asthma is likely to be 
complex, with asthma development requiring the repeated infections, appropriate genetic 
background and allergen exposure (44-48).  Indeed, studies have shown additive or 
synergistic effects of allergen exposure and neonatal RSV (37), PVM (38, 42), influenza 
(39) and RV infection (15).  Further studies are needed to characterize the role of innate 
immune cells, including the ILC2, in combined responses.  
 We would like to add a few caveats about our mouse model of RV infection.  We 
(49) and others (50) have found that a much higher viral titer is required to infect mice 
compared with humans. This finding is to be expected, because differences in the 
homology of viral receptors and intracellular signaling mechanisms are likely to restrict 
viral infection and replication in mice.  Nevertheless, we have clearly shown that human 
RV1B replicates in mouse lungs, as evidenced by: 1) the presence of negative-strand viral 
RNA in the lungs of inoculated mice, 2) transmissibility of RV infection from the lung 
homogenates of inoculated mice to cultured HeLa cells; and 3) the induction of a robust 
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lung interferon response (49). RV replication appears to be augmented in neonatal mice.  
Nevertheless, as in humans, RV infection was not associated with neonatal mortality.  In 
fact, viral titers were relatively low, suggesting that even mild respiratory viral infections 
may elicit an ILC2 response.  These data are consistent with recent speculation by 
workers in the field that relatively innocuous RV infections in early childhood lead to 
sustained changes in the immune response which contribute to the development of 
asthma.    
We conclude that early-life rhinoviral infection could contribute to asthma 
development by provoking age-dependent, IL-25-driven type 2 immune response. IL-25 
induction was regulated in an age-dependent manner and required for ILC2 expansion 
and the development of asthma phenotype in neonates.  Further characterization of this 
immune pathway may lead to new molecular and cellular targets for the prevention of 
asthma. 
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Chapter 3 
 
 
TSLP is required for mucous metaplasia, airways hyperresponsiveness and ILC2 
expansion in RV-infected neonatal mice 
 
Summary 
Early-life respiratory viral infection, in particular with rhinovirus (RV), has been 
identified as a risk factor for asthma development in later life. We have shown that RV 
infection of six-day old but not mature mice causes mucous metaplasia and airway 
hyperresponsiveness which is dependent on IL-13 and IL-25.  In this study, we examined 
the contribution of thymic stromal lymphopoietin (TSLP) to the observed asthma-like 
phenotype.  We hypothesized that, like IL-25, TSLP expression is induced by RV 
infection in immature but not mature mice, and required for mucous metaplasia and 
airways hyperresponsiveness.  We inoculated six day- and eight week-old BALB/c (wild-
type) and TSLP receptor knockout (TSLPR KO) mice with sham HeLa cell lysate or RV.  
Airway responses were assessed by quantitative PCR, ELISA, histology, 
immunofluorescence microscopy and resistance changes to inhaled methacholine.  RV 
infection increased TSLP protein abundance after early-life RV infection while reducing 
TSLP mRNA and protein expression in mature mice.  RV-induced TSLP expression was 
localized to the airway epithelium. Neonatal RV infection induced persistent mucus 
hyperplasia and airway hyperresponsiveness in wild type mice whereas the phenotype 
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was blocked in TSLPR KO mice.  Expansion of type 2 innate lymphoid cells (ILC2s) 
following neonatal RV infection was also significantly inhibited in TSLPR KO mice. 
Finally, when combined with IL-25 and IL-33, TSLP had a direct synergistic effect on 
ILC2 GATA3, IL-13, IL-5, ST2L and IL-17RB mRNA expression. These results show 
that TSLP plays a necessary role in the development of mucous metaplasia, airways 
hyperresponsiveness and ILC2 expansion in RV-infected immature mice.  
 
Introduction 
The onset of asthma is likely to be a result of genetic predisposition, immune 
dysfunction and environmental exposures in early infancy.  One such environmental 
exposure may be viral infection; epidemiologic studies in high-risk infants indicate that 
early-life respiratory viral infection, particularly with rhinovirus (RV), is a major 
predisposing factor for subsequent asthma development (1-4).   
Because the airway epithelium is a major target of respiratory viral infection, the 
epithelium-derived cytokines IL-25, IL-33 and TSLP and their downstream cellular 
targets are uniquely positioned to play a role in viral-induced chronic airways disease.  
IL-25 (5, 6), IL-33 (7) and TSLP (8-11), play a role in the maturation of Th2 cells via 
dendritic cell activation.  IL-25 (12-15), IL-33 (12-14, 16-19) and TSLP (19) also induce 
activation and IL-13 production from innate immune cells including type 2 innate 
lymphoid cells (ILC2s).  Previously, we have found that IL-25 plays pivotal role in 
asthma phenotype development in neonatal mice following RV infection (20).  RV 
infection of six day-old but not mature mice induced mucous metaplasia and airways 
hyperresponsiveness which was accompanied by airway epithelial cell IL-25 production 
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and expansion of IL-13-producing type 2 innate lymphoid cells.  Airway responses were 
blocked by neutralizing antibody against IL-25.   However, we did not examine the role 
of TSLP in this model. 
TSLP is an IL-7-like cytokine which exerts its biological activity via a high-
affinity TSLPR complex that is a heterodimer of the TSLPR chain and IL-7 receptor-α.  
The role of TSLP in the pathogenesis of asthma has been recently highlighted. Several 
single-nucleotide polymorphisms of the TSLP gene locus are associated with asthma 
development (21-24). TSLP levels are increased in the airways of asthmatic patients, and 
this level correlates with asthma severity (25, 26).  Genome-wide association studies have 
found that the TSLP gene locus is associated with asthma risk (27, 28). Treatment of 
human asthmatic patients with anti-TSLP antibody blunted airway responses triggered by 
allergen inhalation (29). In mice, transgenic mice that overexpress TSLP in the lungs 
show an augmented type 2 immune response, goblet cell hyperplasia and subepithelial 
fibrosis when challenged with ovalbumin, whereas TSLPR-deficient mice show an 
attenuated responses (30).  However, less is known about the role of TSLP in the 
development of asthma in childhood.  A recent study showed that RV infection increased 
nasal aspirate TSLP expression in young children (31), consistent with the notion that 
RV-induced TSLP production could play a role in the initiation of asthma.   
We therefore examined the effect of RV infection on TSLP expression in 
immature and mature mice, and the requirement of TSLP for RV-induced mucus 
metaplasia, airway hyperresponsiveness and ILC2 expansion.    
 
Methods 
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Generation of RV.  
RV1B (ATCC, Manassas, VA) was grown in HeLa cells, concentrated and 
partially purified by ultrafiltration, as described (32).  Similarly concentrated and purified 
HeLa cell lysates were used for sham infection. Viral titer was measured by fifty percent 
tissue culture infectivity doses (TCID50) using the Spearman-Karber method (33) or 
plaque assay (34).  For the plaque assay, HeLa cell monolayers were infected with 
serially-diluted RV and overlayed with a 0.6% agarose solution.  Plaque growth was 
monitored by light microscopy and was confirmed by staining with crystal violet. 
 
RV infection.  
Experiments were approved by the Institutional Animal Care and Use Committee. 
BALB/c mice (Jackson Laboratories, Bar Harbor, ME), or TSLPR KO mice (graciously 
supplied by Dr. Steven Ziegler, Benaroya Research Institute, Seattle) were inoculated 
through intranasal route under Forane anesthesia with RV1B (1x10
8
 PFU/ml) or sham 
HeLa cell lysates.  To the mice aged from 5-14 days, 20 μl of RV1B or an equal volume 
of sham were given.  To the mice aged 21 days, 30 μl of RV1B or sham were treated. To 
the mice aged 8 weeks, 50 μl of RV1B or sham were administered. 
  
Assessment of airway responsiveness.  
Airway cholinergic responsiveness was assessed by measuring changes in total 
respiratory system resistance in response to increasing doses of nebulized methacholine 
(35).  Mice were anesthetized with sodium pentobarbital (50 mg/kg mouse, 
intraperitoneal injection) and a tracheostomy performed. Mechanical ventilation was 
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conducted and total respiratory system measured using a Buxco FinePointe operating 
system (Buxco, Wilmington, NC).  Airway responsiveness was assessed by measuring 
changes in resistance in response to increasing doses of nebulized methacholine.  
  
Histology and immunohistochemistry.  
 Lungs were collected and fixed with 10% formaldehyde and paraffin embedded. 
Blocks were sectioned at 500-μm intervals at a thickness of 5 μm, and each section was 
deparaffinized, hydrated, and stained.  To visualize mucus, deparaffinized sections were 
stained with periodic acid-Schiff (Sigma-Aldrich, St. Louis, MO). After antigen 
demasking and permeabilization, sections were also incubated with Alexa Fluor (AF)-
conjugated rabbit anti-mouse TSLP (Thermo Fisher Scientific, Rockford, IL), guinea pig 
antiserum against RV1B (ATCC) or AF-conjugated isotype control IgGs.  Antiserum was 
partially purified by incubation with nitrocellulose-bound HeLa cell proteins and passing 
through an affinity resin containing nondenatured mouse lung protein (36).  Repurified 
antibody was directly conjugated to AF488.  The control used was AF488-conjugated 
guinea pig antiserum. Nuclei were stained with 4′,6-diamidino-2-phenylindole. Images 
were visualized using a Zeiss Axioplan microscope (Thornwood, NY) equipped with an 
ApoTome and digital AxioCamMR charge-coupled device camera.  
  
Measurement of TSLP.   
Whole lung homogenates were collected and centrifuged at full speed for 
supernatant preparation.  The amount of total protein was measured by Pierce BCA 
protein assay kit (Thermo Fisher Scientific).  TSLP concentrations were measured by 
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ELISA (eBioscience, San Diego, CA).  The amount of TSLP in total lung was 
normalized to the total protein in each sample. 
  
 Real-time quantitative PCR.  
 Lung RNA was extracted with Trizol (Invitrogen, Carlsbad, CA) and genomic 
DNA digested using with the combination of on-column digestion of genomic DNA 
(Qiagen, Gaithersburg, MD).   cDNA was synthesized from 1 μg of RNA and subjected 
to quantitative real-time PCR using specific primers for mRNA as described previously 
(20).  The level of gene expression was normalized to GAPDH.  
  
Flow cytometric analysis. 
 Lungs from sham- and RV-treated neonatal wild-type BALB/c or TSLPR KO 
mice were perfused with PBS containing EDTA, minced and digested in collagenase IV.  
Cells were filtered and washed with RBC lysis buffer, and dead cells were stained with 
Pac-Orange Live/Dead fixable dead staining dye (Invitrogen).  To identify ILC2s, cells 
were then stained with FITC-conjugated antibodies for lineage markers (CD3ε, TCRβ, 
B220/CD45R, Ter-119, Gr-1/Ly-6G/Ly-6C, CD11b, CD11c, F4/80 and FcεRIα, all from 
Biolegend), anti-CD25-PerCP-Cy5.5 (Biolegend), anti-CD127-PE-Cy5 (eBioscience), 
and anti-c-kit/CD117-APC (eBioscience), as described (20).  Cells were fixed, subjected 
to flow cytometry and analyzed on a BD Biosciences FACSAria II (BD Biosciences, San 
Jose, CA). Data were collected using FACSDiva software (BD Biosciences) and 
analyzed using FlowJo software (Tree Star, Ashland, OR).  
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Fluorescence-activated cell sorting of ILC2s.  
 After staining for lineage markers, lineage-negative CD25 and CD127 double-
positive ILC2s were sorted at 6.5 X 10
3
 cells/100 μl concentration in each well of 96 well 
plates and stimulated with different factors.  Three days after stimulation, plates were 
centrifuged and supernatant were tested for IL-13 with ELISA (eBioscience). With cell 
pellet, RNA were extracted using RNeasy mini kit (Qiagen), and RNA were concentrated 
using RNA stable (Sigma-Aldrich).  Then, cDNA was synthesized and subjected to 
quantitative real-time PCR using specific primers for mRNA.  The level of gene 
expression was normalized to mRNA of GAPDH. 
  
Data analysis.   
All data were represented as mean ± standard error (SE).  Statistical significance 
was assessed by unpaired t-test, one-way analysis of variance (ANOVA) or two-way 
ANOVA, as appropriate. Group differences were pinpointed by the Student-Newman-
Keuls multiple comparison test.   
   
Results 
TSLP is increased with RV infection in neonatal mice but not in mature mice 
In our previous report, we found that the immune response to RV in neonatal 
mice is qualitatively different from that of mature mice, showing exaggerated type 2 
immune responses leading to mucous metaplasia and airways hyperresponsiveness (20).  
In this study, we hypothesized that TSLP contributes to the observed asthma phenotype.  
We first tested whether the TSLP expression pattern induced by RV is distinctive 
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between immature and mature mice. While TSLP mRNA expression was decreased with 
RV infection in mature mice, TSLP mRNA level was unchanged in neonatal mice 
(Figure 3-1A).  Similar to mRNA, RV infection decreased TSLP protein level in mature 
mice (Figure 3-1B).  In contrast, TSLP protein levels were enhanced in neonatal mice 
with RV infection.  Together, these data provide evidence of both transcriptional and 
post-transcriptional regulation of TSLP expression by RV infection.   
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Figure 3-1. Differential TSLP regulation between immature and mature mice with 
RV infection. Six-day-old and 8-week-old BALB/c mice were inoculated with sham or 
RV (n= 3-8 /each group). A, Lung TSLP mRNA expression was measured 1 to 7 days 
after RV infection with quantitative PCR. B, Lung TSLP protein level was measured with 
ELISA and normalized to total protein. *P < 0.05 compared with sham (unpaired t test). 
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TSLP induction was regulated in an age-dependent manner with RV infection 
To further examine developmental changes in the TSLP response to RV infection, 
we infected different age mice with RV and measured TSLP mRNA and protein.  We 
found that TSLP mRNA was decreased with RV infection in the mice age 8 days or older 
(Figure 3-2A).  Induction of TSLP protein expression was present only in mice ≤ 6 days 
of age (Figure 3-2B).  
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Figure 3-2. Age-dependent changes in TSLP expression after RV infection. BALB/c 
mice of different ages (n= 3-8/group) were inoculated with sham or RV. A, Lung TSLP 
mRNA expression was measured 1 day after infection with quantitative PCR. B, Lung 
TSLP protein level was measured with ELISA and normalized to total protein.  *P<0.05 
versus sham (unpaired t-test) 
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Airway epithelium was the primary source of TSLP with RV infection neonatal mice   
To determine the cellular source of TSLP, we stained the histological sections of 
lungs with anti-TSLP antibody.  RV infection increased TSLP staining in the airways of 
neonatal mice (Figure 3-3).  Both subepithelial and epithelial cells produced TSLP; the 
strongest signals were in the airway epithelial cells, infected with RV.  
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Figure 3-3. RV-induced TSLP expression in neonatal airway epithelium. A, BALB/c 
mice were inoculated with either sham or RV1B. Two days after infection, lungs were 
stained for TSLP (red), RV (green) and nuclei (DAPI, black). (Bar, 100 μm; 
magnification, 400X) 
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TSLPR KO mice showed attenuated mucous metaplasia and airway hyperresponsiveness 
with neonatal RV infection 
Next, we tested the requirement of TSLP for RV-induced mucous metaplasia and 
airway hyperresponsiveness.  RV infection increased PAS staining in wild-type mice, but 
no induction of mucus staining was found in TSLP receptor deficient (TSLPR KO) mice 
(Figure 3-4A).  Consistent with the reduction in PAS staining, induction of IL-13 and the 
mucus-related genes muc5ac, muc5b and gob5 was significantly lower in TSLPR KO 
mice than in wild-type mice (Figure 3-4B). We next measured airway responsiveness.  
Consistent with our previous findings, wild-type mice showed airway 
hyperresponsiveness four weeks after infection.  However, TSLPR KO mice were 
protected against the development of airway hyperresponsiveness (Figure 3-4C).  These 
results demonstrate that TSLP is required for development of the RV-induced asthma 
phenotype. 
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Figure 3-4. Inhibition of mucous metaplasia and airways hyperresponsiveness in 
TSLPR KO mice. Six-day-old BALB/c (WT) mice or TSLPR KO (KO) mice were 
inoculated with sham or RV.  A, Lung sections were prepared 3 weeks after infection and 
stained with PAS solution. Representative lung sections of small airways are shown 
(original magnification, 160X). Scale bar: 100 μm. B, Whole lung gene expression of 
Muc5ac, Muc5b, Gob5 and IL-13 was measured with quantitative PCR. * P < 0.05 
versus sham. C, Six-day-old neonatal BALB/c mice or TSLPR KO mice were inoculated 
with sham or RV and airway cholinergic responsiveness measured 4 weeks after initial 
inoculation. * P < 0.05 versus sham, † P < 0.05 versus TSLPR KO RV (two-way 
ANOVA).   
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Neonatal RV-induced ILC2 expansion was blocked TSLPR KO mice 
In our previous report, we found that ILC2s are increased with neonatal RV 
infection and produce large amounts of IL-13.  Neutralizing antibody against IL-25 
decreased IL-13 production and ILC2 expansion while attenuating mucous metaplasia 
and airways hyperresponsiveness (20).  Utilizing TSLPR KO mice, we tested the 
requirement of TSLP for ILC2 expansion associated with neonatal RV infection.  
Compared to wild-type mice, in which ILC2 was increased with neonatal RV infection, 
the ILC2 population was not expanded in TSLPR KO mice (Figure 3-5).  
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Figure 3-5. Reduction of RV-induced ILC2 expansion in neonatal TSLPR KO mice.  
Six-day-old neonatal BALB/c mice or TSLPR KO mice were inoculated with sham or 
RV. Lungs were collected 14 days after infection, minced and digested in collagenase IV. 
Filtered and washed cells were stained and subjected to flow cytometry. ILC2s were 
identified as lineage-negative, CD25+ CD127+ live cells with low FSC and SSC, as 
described previously (20). A, Representative contour plots and the percentage of lineage-
negative, CD25- and CD127-double positive cells from each group are shown. B, The 
percentage of ILC2s for each group is shown. * P < 0.05 versus sham, † P < 0.05 versus 
mature mice. 
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TSLP synergistically increase ILC2 maturation and function with IL-25 
To better assess the role of TSLP in ILC2 maturation and function, we sorted 
ILC2s and cultured them in the presence or absence of TSLP ex vivo.  Lineage-negative, 
CD25 and CD127 double-positive ILC2s were sorted from the lungs of RV-infected baby 
mice.  As reported previously (12, 37), IL-25 or IL-33, in combination with IL-2, 
increased ILC2 gene expression (Figure 3-6).  Treatment of TSLP further enhanced IL-2- 
and IL-25-induced mRNA expression of IL-17RB, ST2L (the receptors for IL-25 and IL-
33, respectively), GATA3, IL-5 and IL-13.  TSLP also increased IL-2- and IL-33-induced 
IL-5, IL-13 and GATA3 expression, but had no effect on IL-17RB or ST2L. These 
results suggest that TSLP is not only involved in ILC2 expansion in vivo but also has an 
additive effect with IL-25 on ILC2 maturation and function.  
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Figure 3-6. Effect of TSLP on the gene expression of ILC2s. Six-day-old neonatal 
BALB/c mice were infected with RV. Lungs were collected 7 to 10 days after treatment, 
and lung cell suspensions were sorted for Lin- CD25+ CD127+ ILC2s with FACS. 
Sorted ILC2s were seeded at 6.5 x 10
3
 cells/100 μl in 96 well plates. Cells were 
stimulated with the indicated combination of cytokines using the following 
concentrations: IL-2 (50 ng/ml), IL-7 (20 ng/ml), IL-25 (20 ng/ml), IL-33 (20 ng/ml) and 
TSLP (20 ng/ml). After 3 days of stimulation, supernatants were tested for IL-13 protein 
and cell pellets were tested for mRNA expression with quantitative PCR. A, Combined 
effects of TSLP and IL-33 on ILC2 gene expression. B, Combined effects of TSLP and 
IL-25 on ILC2 gene expression. * P < 0.05 versus sham (one-way ANOVA) 
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Discussion  
We have demonstrated previously that neonatal RV infection, but not adulthood 
infection, causes persistent mucus metaplasia and airway hyperresponsiveness (20, 35).  
In the present study, we showed that TSLP is required for full development of the 
observed asthma-like phenotype.  RV infection increased lung TSLP levels in immature 
mice but decreased TSLP level in mature mice. Specific enhancement of TSLP 
expression was observed in the airway epithelium.  Utilizing TSLPR KO mice, we 
showed that, compared to wild-type mice, RV-induced mucus metaplasia and airway 
hyperresponsiveness is significantly blocked in TSLPR KO neonatal mice. RV-induced 
ILC2 expansion was also significantly blocked in TSLPR KO neonatal mice.  Finally, we 
found that, in the presence TSLP, IL-25-stimulated ILC2s express higher levels of 
GATA3, IL-17RB, ST2L, IL-5 and IL-13 ex vivo, evidence of more potent activation.  
These results suggest that TSLP plays an indispensible role in development of airway 
responses with neonatal RV infection. 
Previous cell culture and animal studies have linked viral infection, TSLP 
response and the development of airways disease.  RV16 induces TSLP expression in 
primary human bronchial epithelial cells (38, 39), and RSV and influenza have similar 
effects (40, 41).  Airway epithelial cells from asthmatic children produce greater levels of 
TSLP after RSV infection than cells from healthy children (42).   RSV infection of 
mature mice increases IL-13 levels, mucus production and airways hyperresponsiveness 
which was reduced in TSLPR KO mice (42).    
In contrast to RSV, we have found that the airway response of mice to RV 
infection is dependent on the age of the infection.  We previously found that the levels of 
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IL-13 and IL-25, which are required for the development of asthma phenotype, are only 
increased in immature mice after RV infection (20).  IFN-γ levels were only increased 
after adult infection.  Further, there was dramatic switch in the immune response to RV at 
approximately 6-8 days of life.  In this report, we found similar changes in the RV-
induced TSLP response, with increased TSLP protein levels in 4-6 day-old mice and 
decreased expression thereafter.  To our knowledge, this is the first report showing 
developmental regulation of the TSLP response after respiratory viral infection.  This 
age-dependent induction of TSLP is consistent with the association between nasal 
aspirate TSLP protein levels and RV in young children (31).  We have not established the 
specific mechanism underlying the observed switch in immune phenotype,   Previous 
studies have found that the immature immune system is qualitatively different from that 
of adult, refractory to type 1 and permissive to type 2 responses (43-51).  Interestingly, 
we found that TSLP induction in immature animals was in part regulated by post-
transcriptional mechanisms (translation or secretion), in contrast to mature animals in 
which TSLP mRNA expression was suppressed.  IFN-γ has been shown to inhibit 
double-stranded RNA-induced TSLP production in fibroblasts (52) and keratinocytes 
(53).  It is therefore conceivable that the strong IFN-γ response to RV infection in mature 
mice blocked the induction of TSLP.    
TSLP expression following RV infection was primarily localized to the airway 
epithelium.  However, subepithelial cells were also identified, similar to human asthmatic 
airways (25).  Other potential cellular sources include neutrophils, mast cells, 
macrophages and eosinophils.  
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In our previous work, we found that ILC2s are increased in immature mice 
following RV infection, and that ILC2 produce ample amounts of IL-13 ex vivo (20).   
Further, administration of anti-IL-25 decreased ILC2 number and lung IL-13 while 
preventing RV-induced mucous metaplasia and airways hyperresponsiveness.  These data 
are consistent with the notion that IL-25 is required for ILC2 expansion and function, as 
has been shown previously (14).  In this report, we present evidence that TSLP is also 
required for ILC2 expansion and function.  RV infection failed to increased lung ILC2 
cells in TSLPR KO mice, and TSLP increased ILC2 gene expression ex vivo.  Early 
studies identifying ILC2s as critical regulators of allergic responses highlighted the 
cooperative roles of IL-25 and IL-33 in the ILC2 response (12, 13, 16).  In contrast, 
TSLP was reported to be a driver of Th2 cell (8, 10, 11) and basophil development (54, 
55).  However, it was later determined that ILC2 cells produce large amounts of IL-5 and 
IL-13 when stimulated by IL-33 plus TSLP (11, 19, 37), and also that ILC2s express high 
levels of TSLPR (37).  Most recently, it was shown that TSLP is required for IL-33-
induced ILC2 proliferation and steroid-resistant airways hyperresponsiveness (56).   We 
now provide further evidence that TSLP promotes ILC2 expansion in vivo.  Further, our 
data demonstrating that TSLP has additive effects on IL-25-induced expression of IL-5, 
IL-13 and IL-17RB, combined with our previous work (20), support a cooperative 
relationship between TSLP and IL-25 in the response to early-life viral infection.    
Early-life wheezing-associated respiratory tract infections have long been 
considered risk factors for asthma.  While initial attention focused on the potential role of 
respiratory syncytial virus, evidence also exists for an association between early-life RV 
infection and asthma.  In Finnish infants hospitalized for respiratory infection-associated 
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wheezing, RV was associated with asthma development in contrast to RSV, which was 
negatively associated (1).  Data from a birth cohort of high-risk infants from Madison, 
Wisconsin showed that wheezing-associated illness with RV is the most important risk 
factor for asthma development, higher than that of infants with allergen sensitization or 
RSV infection (2, 3). A population-based retrospective analysis of a birth cohort of 
90,000 Tennessee children showed an increased risk of early childhood asthma following 
bronchiolitis during RV-predominant non-winter months vs. RSV-predominant winter 
months (4). Together, these data are consistent with the notion that early-life viral 
infections, including those with RV, perhaps in combination with other factors such as 
genetic background, allergen exposure and microbiome, modulate the immune response, 
increasing the likelihood of childhood asthma development.  Our data are consistent with 
the notion that infants are susceptible to asthma development following RV infection, 
We conclude that TSLP is required for persistent mucus metaplasia and airway 
hyperresponsiveness as well as ILC2 expansion with neonatal RV infection. Similar to 
IL-13 and IL-25, the TSLP response to viral infection was developmentally regulated.  
This research further supports the notion that TSLP may play a role in asthma 
development.      
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Chapter 4 
 
IL-4 receptor signaling determines macrophage activation state and response to 
rhinovirus infection in a mouse model of allergic asthma  
  
Summary 
In contrast to the potential role of early life viral infections in asthma 
pathogenesis, the contribution of viruses to asthma exacerbations is well-established.  
However, the mechanisms by which viruses cause asthma exacerbations are not precisely 
known.  In this chapter, we examine the role of another innate immune cell, the 
macrophage, in asthma attacks.  Previously, we showed that, in ovalbumin (OVA)-
sensitized and -challenged mice with allergic airway inflammation, rhinovirus (RV) 
infection increases type 2 cytokine production from alternatively-activated (M2) airway 
macrophages, enhancing eosinophilic inflammation and airways hyperresponsiveness.  In 
this paper, we tested the hypothesis that IL-4 signaling determines the state of 
macrophage activation and pattern of RV-induced exacerbation in mice with allergic 
airways disease.  To resolve this issue, eight week-old wild type or IL-4 receptor 
knockout (IL-4R KO) mice were sensitized and challenged with OVA and inoculated 
with RV1B or sham HeLa cell lysate.  In contrast to OVA-treated wild-type mice with 
both neutrophilic and eosinophilic airway inflammation, OVA-treated IL-4R KO mice 
showed increased neutrophilic inflammation with few eosinophils in the airways.  Like 
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wild-type mice, IL-4R KO mice showed OVA-induced airway hyperreactivity which was 
further exacerbated by RV. There was a shift in lung cytokines from a type 2-
predominant response to a type 1 response, including production of IL-12p40 and TNF-α.  
IL-17A was also increased.  RV infection of OVA-treated IL-4R KO mice further 
increased neutrophilic inflammation.  Bronchoalveolar macrophages showed an M1 
polarization pattern and ex vivo RV infection increased macrophage production of TNF-
α, IFN-γ and IL-12p40.   Finally, lung cells from OVA-treated IL-4R KO mice showed 
reduced CD206+ CD301+ M2 macrophages, decreased IL-13 and increased TNF-α and 
IL-17A production by F4/80+, CD11b+ macrophages.   
In conclusion, OVA-treated IL-4R KO mice show neutrophilic airway inflammation 
constituting a model of allergic, type 1 cytokine-driven neutrophilic asthma.  In the 
absence of IL-4/IL-13 signaling, RV infection of OVA-treated mice increased type 1 
cytokine and IL-17 production from conventionally-activated macrophages, augmenting 
neutrophilic rather than eosinophilic inflammation.  In mice with allergic airways 
inflammation, IL-4R signaling determines macrophage activation state and the response 
to subsequent RV infection.   
 
Introduction 
Macrophages are innate immune cells that play a critical role in early phases of 
host defense against pathogens, coordination of the adaptive immune response, and the 
regulation of inflammation and tissue repair.  Through activation signals by various 
ligands and environmental cues, macrophages may change their polarization state, 
leading to altered immune responses.  In the presence of type 1 cytokines such as 
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interferon- and IL-12, macrophages are activated in a classical manner (M1-polarized) 
and produce pro-inflammatory cytokines and toxic mediators.  In the presence of the type 
2 cytokines IL-4 and IL-13, alternatively-activated (M2-polarized) macrophages express 
a distinct pattern of phagocytic receptors (1) and produce type 2 cytokines which play a 
role in anti-parasitic and allergic responses, including asthma.  IL-13-overexpressing 
transgenic mice infected with C. neoformans demonstrate alternatively-activated 
macrophages expressing Arg-1, macrophage mannose receptor (CD206) and Ym-1, as 
well as lung eosinophilia, goblet cell metaplasia, elevated mucus production and airway 
hyperreactivity (2).  Adoptive transfer of IL-4Rα+ alternatively-activated macrophages 
enhances eosinophilic inflammation in ovalbumin (OVA)-sensitized and -challenged 
mice (3).  Moreover, CD206 is increased in the asthmatic patients and correlates with the 
severity of asthma (4).   
 Viral-induced exacerbations are a major cause of morbidity in asthma.  
Rhinovirus (RV), a single-stranded RNA virus belonging to Picornavirus family, is 
consistently the most frequent pathogen identified.  However, the precise mechanisms 
underlying RV-induced asthma exacerbations are not known.  Compared to normal 
subjects, asthmatic patients with RV infection show enhanced neutrophilic and 
eosinophilic inflammation in the lower airways (5), consistent with the notion that 
asthmatics have a qualitatively different immune response to RV infection than controls.  
To test this in an animal model, we exposed OVA-sensitized and -challenged mice with 
allergic airways disease to RV1B, a minor group virus which infects mouse epithelial 
cells (6).  We found that RV increased airway hyperresponsiveness and eosinophilic 
inflammation, and that RV colocalized with eotaxin-producing, CD68-positive lung 
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macrophages in vivo.  Macrophages from OVA-treated mice showed increased 
expression of arginase-1, Ym-1 and Mgl-2, indicating a shift in macrophage activation 
status, and RV inoculation of lung macrophages from OVA-treated mice induced 
expression of eotaxin-1, IL-4, and IL-13 ex vivo.  Depletion of macrophages from OVA-
sensitized and -challenged mice reduced eosinophilic inflammation following RV 
infection.  Together, these results suggest that RV causes asthma exacerbations in part by 
infection of alternatively-activated macrophages.  Finally, exposure of macrophages from 
naïve mice to IL-4 and IL-13 significantly increased RV-induced eotaxin mRNA 
expression, consistent with the notion that type 2 cytokines are sufficient to alter the 
response of macrophages to RV infection.  
 In the present study, we hypothesized that IL-4 signaling regulates the state of 
macrophage activation and the pattern of RV-induced exacerbation in mice with allergic 
airways disease.  We anticipated that, in the absence of IL-4/IL-13 signaling, RV 
infection would preferentially increase type 1 cytokine production from conventionally-
activated macrophages, augmenting neutrophilic rather than eosinophilic inflammation.  
To test this, we sensitized and challenged wild-type and IL-4 receptor knockout (IL-4R 
KO) mice with OVA and then infected these animals with RV.  We found that OVA-
treated IL-4R KO mice showed neutrophilic airway inflammation which was exacerbated 
by RV infection.  Macrophages from OVA-treated mice showed an M1 polarization 
pattern and expressed type 1 cytokines and IL-17 in response to ex vivo RV infection.  
OVA-treated IL-4R KO mice showed decreased IL-13 and increased TNF-α and IL-17 
production with RV infection by F4/80+, CD11b+ macrophages, demonstrating that IL-
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4R signaling determines macrophage activation state and the response to subsequent RV 
infection.   
 
Methods 
Generation of HRV.  
 HRV1B (ATCC, Manassas, VA) were grown in cultured HeLa cells, 
concentrated, partially purified and titered as described previously (7). Similarly 
concentrated and purified HeLa cell lysates were used for sham infection. 
  
OVA sensitization and challenge.   
All animal experiments were approved by the University of Michigan Institutional 
Animal Care and Use Committee.   Female 8 wk-old BALB/c mice (Jackson 
Laboratories, Bar Harbor, MA) or age-matched BALB/c-Il4ra
tm1Sz
/J IL-4R KO mice 
(Jackson Laboratories) were injected intraperitoneally on days 0 and 7 with 0.2 ml PBS 
or a solution of alum and 100 µg endotoxin-free OVA (Sigma-Aldrich, St. Louis, MO).  
Next, mice were challenged intranasally with 50 µl of PBS or 100 µg OVA on days 12 
and 13.  Selected mice were inoculated with sham or RV1B on day 14, and mice were 
harvested for analysis on day 15.    
 
RV exposure.   
Selected mice were inoculated intranasally with 50 ul of 1x10
8
 TCID50/ml RV1B, 
or an equal volume of sham control immediately following the last OVA treatment.  
Lungs were collected 24 hr post infection for further analysis. 
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Assessment of airway responsiveness. 
 Airway cholinergic responsiveness was assessed by measuring changes in total 
respiratory system resistance in response to increasing doses of nebulized methacholine, 
as described previously (8). Mice were anesthetized with sodium pentobarbital (50 mg/kg 
mouse, intraperitoneal injection) and a tracheostomy performed. Mechanical ventilation 
was conducted and total respiratory system measured using a Buxco FinePointe operating 
system (Buxco, Wilmington, NC). Airway responsiveness was assessed by measuring 
changes in resistance in response to increasing doses of nebulized methacholine.  
 
Bone marrow-derived macrophage cultures.  
 Femurs were harvested from naïve wild-type BALB/c and IL-4R KO mice and 
the bone marrow was used to expand macrophages for in vitro analyses.  Dissociated 
marrow cells were plated onto 12-well culture dishes at 1x10
6
 cells/ml and cultured for 6 
days in RPMI supplemented with 30% L929-conditioned medium and 10% heat-
inactivated fetal bovine serum (9). Cells were stimulated for 1.5 h with medium or RV1B 
(multiplicity of infection, 10) and RNA harvested 8 h after infection. 
 
Mouse bronchoalveolar inflammatory cells and macrophage culture. 
 Bronchoalveolar lavage (BAL) was performed using 1 ml PBS aliquots, and 
differential cell counts were performed using the DiffQuick method.  BAL fluid from 
PBS- and OVA-treated mice was seeded in 24 well plates.  BAL macrophages were 
purified by plastic adherence, which yielded >90% purity.  Cells were stimulated for 1.5 
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h in the presence or absence of HRV1B (multiplicity of infection, 10), and harvested 8 or 
24 h after infection for RNA and protein analysis.  
 
Cytokine/chemokine expression.  
Lung RNA was extracted with Trizol (Sigma-Aldrich) and analyzed for cytokine 
and chemokine gene expression by quantitative real-time PCR using specific primers and 
probes. Signals were normalized to GAPDH. BAL fluid was spun for 15 min at 1500 
rpm, and the supernatants were analyzed for cytokine protein by multiplex immune assay 
(Bio-Rad, Hercules, CA) or ELISA (R&D Systems, Minneapolis, MN). 
 
Histology, immunohistochemistry and immunofluorescence microscopy.  
Lungs were fixed with 10% formaldehyde overnight and paraffin embedded.  
Blocks were sectioned at 500 µm intervals at a thickness of 5 µm and each section was 
deparaffinized, hydrated and stained with hematoxylin and eosin.  Other sections were 
stained with rabbit anti-mouse IL-17 (Abcam, Cambridge, MA).  For 
immunohistochemistry, sections were incubated with biotinylated secondary goat-IgG, 
ABC reagent (Vector Laboratories, Burlingame, CA), diaminobenzidine (DAB, Sigma-
Aldrich) and Gill’s hematoxylin (Fisher Scientific, Kalamazoo, MI).  For fluorescence 
microscopy, slides were incubated with Alexa Fluor (AF)-555-conjugated rat anti-mouse 
CD68 and AF488-conjugated rabbit anti-mouse IL-17 or AF-conjugated isotype control 
IgGs.  Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI).  Images were 
visualized using a Olympus IX71inverted phase/epifluorescence microscope and digital 
CCD camera. 
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Flow cytometric analysis. 
 Lungs from mice were perfused with PBS containing EDTA, minced and 
digested in collagenase IV. Cells were filtered and washed with RBC lysis buffer, and 
stimulated with for 5 h with cell stimulation cocktail (eBioscience, San Diego, CA) 
containing PMA, ionomycin and protein export blockers. After stimulation, dead cells 
were stained with Pac-Orange Live/Dead fixable dead staining dye (Invitrogen, Carlsbad, 
CA). Cells were then stained with anti-CD45-PacBlue, anti-TCRβ-FITC, anti-F4/80-PE-
Cy5, anti-CD11c-APC, anti-CD11b-APC-Cy7, anti-CD68-PerCP-Cy5.5, anti-CD301 
conjugated with Alexa Fluor (AF)-633 and anti-CD206 conjugated with AF488 (all 
antibodies from Biolegend, San Diego, CA). Cells were fixed, permeabilized and 
incubated with anti-IL-13-PE (eBioscience), anti-IL-17A-PE-Cy7 antibody (Biolegend) 
or anti-TNF-α-PE-Cy7 antibody (Biolegend). Stained cells were subjected to flow 
cytometry and analyzed on a BD Biosciences FACSAria II (BD Biosciences, San Jose, 
CA). Data were collected using FACSDiva software and analyzed using FlowJo software 
(Tree Star, Ashland, OR).  
 
Data analysis.   
 Data are represented as mean±SEM.  Statistical significance was assessed by 
student’s t test, unpaired t test, one-way analysis of variance (ANOVA), two-way 
ANOVA, ANOVA based on ranks, as appropriate.  Differences were pinpointed by the 
Bonferroni or Newman-Keuls multiple comparisons test.   
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Results 
RV infection elicit differential cytokine response from wild-type and IL-4R KO 
macrophages. 
We previously found that, in OVA-sensitized and -challenged mice with allergic 
airway inflammation, RV infection increases eotaxin-1, IL-4 and IL-13 production from 
alternatively-activated (M2 polarized) airway macrophages, further enhancing 
eosinophilic inflammation and airways hyperresponsiveness (6).  We also found that in 
vitro exposure of macrophages from naïve mice to IL-4 and IL-13 significantly increased 
RV-induced eotaxin mRNA expression, consistent with the notion that type 2 cytokines 
are sufficient to alter the response of macrophages to RV infection.  In the present study, 
we hypothesized that IL-4 signaling determines the state of macrophage activation and 
pattern of RV-induced exacerbation in mice with allergic airways disease.  First, we 
tested the responses of bone marrow-derived macrophages from naïve wild-type and IL-
4R KO mice.  Dissociated marrow cells were differentiated to macrophages in L929-
conditioned medium (9). Macrophages from naïve wild-type mice showed significant 
increases in IL-1β, TNF-α, CXCL1 and CXCL2 mRNA expression in response to RV 
infection ex vivo (Figure 4-1).  Bone marrow-derived macrophages from naïve IL-4R KO 
cells also showed increases in IL-1β, TNF-α, CXCL1 and CXCL2 mRNA expression.  
However, compared to control cells, IL-4R KO cells demonstrated significantly increased 
IL-1β and CXCL2 in response to RV infection.  Further, in contrast to cells from wild-
type mice, RV infection of macrophages from naïve IL-4R KO mice significantly 
increased mRNA expression of IL-17A and IL-6. These results suggest that, in the 
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absence of IL-4R signaling, macrophages show an exaggerated type 1 phenotype and 
increased IL-17 production in response to RV infection. 
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Figure 4-1.  Responses of bone marrow-derived macrophages to RV infection.  
Dissociated marrow cells from wild-type and IL-4R KO mice were differentiated to 
macrophages in L929-conditioned medium.  Compared to control cells, IL-4R KO cells 
demonstrated increased RV-induced cytokine responses.  (Mean±SEM, n=3, *different 
from medium, P < 0.05, one-way ANOVA; †different from wild-type, P < 0.05, one-way 
ANOVA) 
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Immune responses to OVA challenge and RV infection were differentially regulated in the 
absence of IL-4R signaling 
 Next, we examined the effect of IL-4R KO in mice sensitized and challenged with 
OVA.   As expected, OVA treatment of wild-type mice significantly increased the total 
number of BAL cells (Figure 4-2A), augmenting the number of neutrophils and 
eosinophils (Figure 4-2B and C).  RV infection of wild-type mice further increased lung 
inflammation, resulting in an additional 2-fold increase in BAL cells.  Both neutrophils 
and eosinophils were increased in the BAL following RV infection.   In IL-4R KO mice, 
OVA sensitization and challenge was also accompanied by a significant increase in BAL 
inflammatory cells (Figure 4-2A).  The inflammatory cells consisted nearly exclusively 
of neutrophils, and the number of eosinophils in the airways was significantly reduced 
compared to wild-type mice (Figure 4-2B and C).  When OVA-treated IL-4R KO mice 
were infected with RV, neutrophil infiltration further increased (Figure 4-2D).  In 
contrast to wild-type mice, RV did not induce eosinophilic inflammation.  Finally, we 
found that, similar to wild type mice, IL-4R KO mice showed OVA-induced airway 
hyperreactivity which was further exacerbated by RV (Figure 4-2E and F). Together, 
these results show that IL-4 receptor signaling is not required for allergen-induced airway 
inflammation or hyperresponsiveness. Instead, the immune responses to OVA challenge 
and RV infection were differentially regulated in the absence of IL-4R signaling, 
accentuating neutrophilic rather than eosinophilic inflammation.  
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Figure 4-2.  Airway inflammation and airway hyperresponsiveness in OVA-treated 
wild-type and IL-4R KO mice.  Eight-week old wild-type or IL-4R KO mice were 
treated with PBS or OVA and inoculated with sham or RV. Bronchoalveolar lavage was 
performed 24 hour post-inoculation.  After counting the total number of cells, cytospins 
were performed and stained with Diff-Quick, and differential counts determined from 
200 cells. (A) RV infection increases the total number of BAL cells in OVA-sensitized 
and -challenged wild-type and IL-4R KO mice.  (B) RV infection increases the number 
of airway neutrophils in OVA-treated wild-type and IL-4R KO mice.  The neutrophil 
response was significantly higher in IL-4R KO mice.  (C) RV infection increases the 
number of airway eosinophils in OVA-treated wild-type mice.  The eosinophil response 
was significantly attenuated in IL-4R KO mice. (Mean±SEM, n=3, *different from 
medium, p<0.05, one-way ANOVA; †different from wild-type, p<0.05, one-way 
ANOVA.)  (D) Hematoxlin and eosin staining of airway from OVA- and RV-treated IL-
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4R KO mouse.  Neutrophils are present in the airway lumen, bronchovascular bundle and 
some alveolar spaces.  (E & F)  Airway cholinergic responsiveness was assessed by 
measuring changes in total respiratory system resistance in response to increasing doses 
of nebulized methacholine. Data from wild type (E) and IL-4R KO mice (F) are shown.  
(Mean±SEM, n=4-6 in each group, *different from sham, P < 0.05, two-way ANOVA; 
†different from PBS, P < 0.05, two-way ANOVA).  
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Exaggerated type 1 immune response to RV in OVA-treated IL-4R KO mice.  
 To determine the factors driving neutrophilic inflammation in IL-4R KO mice, we 
analyzed lung mRNA expression by qPCR (Figure 4-3A). In OVA-treated wild-type 
mice, RV treatment increased TNF-α, IFN-γ, CCL2, CCL3 and IL-4 mRNA expression.  
RV infection of OVA-treated IL-4R KO mice significantly increased TNF-α, IFN-γ, 
CXCL1, IL-12p40, CCL2, CCL3 and IL-17 mRNA levels.  Finally, compared to OVA-
treated, RV-infected wild-type mice, OVA-treated, RV-infected IL-4R KO mice showed 
increased IL-12p40 and IL-17A mRNA expression.  Considering the neutrophil-
recruiting ability of TNF-α and CXCL1 (10, 11), and the capacity of IL-17A to indirectly 
stimulate recruitment of neutrophils into the airways via the induction of C-X-C 
chemokines (12-17), these results suggest that neutrophilic inflammation in the airways 
of OVA-treated IL-4R KO mice was mediated, at least in part, by the induction of TNF-
α, CXCL1 and IL-17A.  We also examined BAL fluid protein levels (Figure 4-3B).  We 
found that, compared to similarly-treated wild type mice, TNF-α and IL-12p40 levels 
were significantly higher in the lungs of OVA-treated, RV-infected IL-4R KO mice, 
consistent with an enhanced type I immune response.  
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Figure 4-3.  Cytokine expression in lungs of OVA-treated wild-type and IL-4R KO 
mice. Wild-type or IL-4R KO mice were sensitized and challenged with OVA and 
inoculated with sham or RV. (A)  After 24 h, lungs were collected and gene expression 
measured by qPCR.  (B) TNF-α and IL-12p40 protein in the BAL fluid was assessed with 
multiplex immune assay. (Mean±SEM, n=3-6 each group, *different from sham, P < 
0.05, one-way ANOVA; †different from wild-type, P < 0.05, one-way ANOVA.)  
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IL-4R KO macrophages are polarized towards an M1 phenotype, leading to a differential 
response to RV infection compared to wild-type mice.   
 To examine the specific role of the macrophage in airway neutrophilic responses, 
we isolated adherent BAL cells (>90% macrophages) from OVA-sensitized and -
challenged wild-type and IL-4R KO mice and infected them with RV ex vivo.  As shown 
previously (6), macrophages from wild-type mice treated with OVA expressed high 
levels of the M2 marker Arg 1 and Ym-1, and expressed the type 2 cytokines IL-4, IL-13 
and CCL-24 upon RV infection, typical of alternative activation (Figure 4-4A).  RV 
infection also stimulated mRNA expression of CCL2 in macrophages from wild-type 
mice.  In contrast, macrophages from OVA-treated IL-4R KO mice failed to express 
significant levels of Arg-1, Ym-1 or and CCL24, and did not express IL-4 or IL-13 
mRNA with RV infection.  Compared to cells from wild-type mice, CCL2 expression 
was decreased in cells from IL-4R KO mice.  On the other hand, IL-4R KO macrophages 
showed more potent type 1 cytokine responses to RV infection, including TNF-α, IFN- 
and IL-12p40.  Moreover, the basal level of IL-17A gene expression was increased in 
macrophages from OVA-treated IL-4R KO mice.  Analysis of macrophage supernatants 
confirmed increased production of TNF-α and IL-17A protein in cells from IL-4R KO 
mice (Figure 4-4B).  These results suggest that, upon OVA treatment, IL-4R KO 
macrophages are polarized towards an M1 phenotype, leading to a differential response 
to RV infection compared to wild-type mice.    
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Figure 4-4.  Differential cytokine expression in RV-stimulated macrophages from 
OVA-treated wild-type and IL-4R KO mice. Macrophages were collected from the 
BAL of OVA-treated wild-type or IL-4RKO mice. Macrophages were selected by 
allowing adherence to plastic for 2 h.  Macrophages were treated with medium or RV 
(multiplicity of infection, 5) for 1.5 hours. Cells were collected 8 h or 24 h after infection 
for RNA and protein analysis.  (A) Gene expression in macrophage was measured by 
qPCR. (B) TNF-α and IL-17A protein levels were assessed with ELISA. (Data represent 
three independent experiments, mean±SEM, n=3-8 each group, *different from sham, P 
< 0.05, one-way ANOVA; †different from wild type, P < 0.05, one-way ANOVA).  
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IL-4 signaling is required for alternative activation of lung macrophages and production 
of IL-13 with OVA treatment. 
Next, we examined the effect of IL-4R KO on macrophage activation in vivo.  We 
reasoned that, in the absence of IL-4R signaling, RV infection of OVA-sensitized and -
challenged mice would fail to induce type 2 cytokine production and, instead, increase 
type 1 and IL-17 cytokine production from conventionally-activated macrophages, 
augmenting neutrophilic rather than eosinophilic inflammation.   Lungs of wild type and 
IL-4R KO mice were examined by flow cytometric analysis.  Lung cell suspensions were 
stained with antibodies against macrophage surface markers.  As we found previously 
(6), in wild-type mice, expression of the macrophage alternative activation markers 
CD206 and CD301 was enhanced after OVA challenge (Figure 4-5A).  Further, IL-13 
production by CD11b+ macrophages was increased with OVA treatment and further 
increased with RV infection (Figure 4-5B and C).  In contrast, in IL-4R KO mice, neither 
CD206 and CD301 expression (Figure 4-5A) nor IL-13 (Figure 4-5B and C) increased 
after OVA treatment or RV infection. These data suggest that IL-4 signaling is required 
for alternative activation of lung macrophages and production of effector cytokine IL-13 
in this experimental system. 
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Figure 4-5. Differential expansion of CD206+ CD301+ M2-polarized macrophages 
and IL-13 production in wild-type and IL-4R KO mice. Eight-week old wild-type or 
IL-4R KO mice were treated with PBS or OVA by intraperitoneal injection (days 0, 7) 
and intranasal installation (days 12, 13). Mice were intranasally inoculated with sham or 
RV on day 14. Lungs were harvested and minced in collagenase IV solution. (A) Cells 
were stained with antibodies against macrophage surface markers and assessed with flow 
cytometric analysis.  CD206- and CD301-double positive cells in the CD11b+ cell 
fraction are shown. (B) Cells were incubated with cell stimulation cocktail for 5 h, 
stained, and analyzed with flow cytometric method. Expression of CD11b and IL-13 was 
analyzed among CD45+ cells. The numbers represent the percentage of cells within each 
quadrant. (C) The percentage of CD11b+ IL-13+ cells were shown among CD45+ 
fraction. 
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RV infection increased TNF and IL-17A expression in macrophages of OVA-treated IL-
4R KO mice. 
 Next, we asked whether type 1 cytokine production is increased in macrophages 
from OVA-treated IL-4R KO mice in vivo. We collected the lungs of wild type and IL-
4R KO mice, stained for TNF-α and analyzed with flow cytometry. We found that, 
compared to wild-type mice, TNF-α producing CD45+, F4/80+, CD11c-, CD11b+ 
macrophages were increased in OVA-treated IL-4R KO mice, and these cells were 
further increased with RV infection (Figure 4-6A and B).  
To test whether macrophages secrete IL-17A in vivo, we examined the lungs of 
wild type and IL-4R KO mice by flow cytometric analysis.  We found that CD45+, 
TCRβ-, CD68+, F4/80+, CD11c-, CD11b+, IL-17A+ macrophages were increased in 
naïve IL-4R KO mice compared to wild-type mice, and further enhanced with RV 
infection (Figure 4-6C and D).  We also employed immunohistochemistry and 
immunofluorescence microscopy to confirm IL-17 localization in lungs from OVA-
treated IL-4R KO mice.  IL-17-positive monocytic cells were evident in the 
subepithelium (Figure 4-6E).  IL-17 co-localized with CD68, a macrophage marker 
(Figure 4-6F).   
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Figure 4-6. TNF-α and IL-17A expression in macrophages of wild-type and IL-4R 
KO mice. Wild-type or IL-4R KO mice were sensitized and challenged with OVA and 
inoculated with sham or RV. (A) Lungs were harvested and digested with collagenase IV. 
Cells were stimulated with cell stimulation cocktail for 5h and stained with antibodies 
against macrophage surface markers, fixed, permeabilized and incubated with anti-TNF-
α. CD11b+ TNF-α+ cells were analyzed in the CD45+ F4/80+ CD11c- fraction.  A 
fluorescent minus one (FMO) control was utilized to confirm TNF-α signals. (B) The 
percentage of CD45+, F4/80+, CD11c-, CD11b+, TNF-α cells in the CD45+ F4/80+ 
CD11c- fraction (upper panel) and total CD45+ TNF-α+ cells (lower panel) were 
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calculated. (C)  IL-17A producing macrophages were assessed by flow cytometry.  Lung 
cells were stained with anti-IL-17A.  CD45+, CD68+, F4/80+, CD11c- cells were 
analyzed for CD11b and IL-17A.  An FMO control was utilized to confirm IL-17A 
signals. (D)  The percentage of CD45+, CD68+, F4/80+, CD11c-, CD11b+, IL-17A+ 
cells in the CD45+ CD68+ fraction (upper panel) and total CD45+ IL-17A+ cells (lower 
panel) were calculated. (E) Lung sections were stained with anti-IL-17A antibody.  
Immunohistochemistry shows DAB staining of round cells in the airway subepithelium.  
(F) Lungs were stained with AF555-conjugated anti-CD68 (red) and AF488-conjugated 
anti-IL-17A (green).  Nuclei were stained with DAPI (blue). Immunofluorescence shows 
colocalization (yellow), indicating IL-17A production by CD68-positive macrophages.  
(Mean±SEM, n=3-5 each group, *different from sham, P < 0.05, one-way ANOVA; 
†different from wild-type, P < 0.05, one-way ANOVA).   
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Discussion  
Viral-induced exacerbations are a major cause of morbidity in asthma.  RVs 
comprise approximately 50% of the viruses isolated.  However, the precise mechanisms 
underlying RV-induced asthma exacerbations are not known.  RV, unlike influenza and 
other viruses, causes minimal if any cytotoxicity (18, 19).  The current explanation is that 
RV infection induces the release of chemokines from airway epithelial cells, thereby 
attracting inflammatory cells to the airways.  However, it is also conceivable that RV 
directly infects airway inflammatory cells.  Several studies have examined the infection 
of monocytic cells by RV in vitro (20-25).  Recently, we found that, in both mice and 
humans, RV colocalizes with monocytes in vivo (6, 26).  Following infection of OVA-
sensitized and -challenged mice, we found that RV colocalized with eotaxin-producing, 
CD68-positive lung macrophages.  Compared to cells from untreated mice, BAL 
macrophages from allergen-treated mice showed increased expression of type 2 and 
decreased expression of type I cytokines in response to ex vivo RV infection, indicating a 
shift from M1 to M2 activation status.  Finally, depletion of macrophages using 
clodronate liposomes reduced RV-induced eosinophilic inflammation and airway 
hyperreactivity, suggesting that RV causes asthma exacerbations in part by infection of 
alternatively-activated macrophages.  
We hypothesized that IL-4 signaling drives the state of macrophage activation and 
determines the pattern of RV-induced exacerbation in mice with allergic airways disease.  
To test this in an animal model, we examined the effect of RV infection on OVA-
sensitized and  -challenged wild-type and IL-4R KO mice. We anticipated that, in the 
absence of IL-4/IL-13 signaling, RV infection would increase type 1 cytokine production 
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from conventionally-activated macrophages, augmenting neutrophilic rather than 
eosinophilic inflammation.  We found that OVA increased the number of CD206+, 
CD301+ M2-polarized lung macrophages and IL-13+ CD11b+ cells in wild type but not 
IL-4R KO mice.  In addition, unlike OVA-exposed wild-type mice with mixed 
neutrophilic and eosinophilic inflammation, OVA treatment of IL-4R KO mice induced 
airway inflammation which was almost exclusively neutrophilic in character.  When 
OVA-treated IL-4R KO mice were infected with RV, neutrophil infiltration further 
increased.  Neutrophilic inflammation was associated with increased lung type 1 cytokine 
expression, and BAL macrophages expressed type 1 cytokines in response to RV 
infection ex vivo.  Together, these results show that IL-4 signaling is required for lung 
macrophage M2 polarization, and that macrophage polarization state determines the 
response to RV infection (Figure 4-7).  
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Figure 4-7. Macrophage activation state determines the response to subsequent 
rhinovirus infection.  Upon airway injury, individuals with a type 2-predominant 
immune response experience eosinophilic airway inflammation which is heightened by 
RV infection.  Alternatively. individuals with a type 1/IL-17-predominant response 
(analogous to IL-4R KO mice) demonstrate neutrophilic inflammation which is 
exacerbated by RV infection.  
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In this study, we found that IL-17A was increased in the lungs of OVA-treated 
IL-4R KO mice and expressed by BAL and lung macrophages infected with RV.  IL-17A 
plays an important role in the recruitment and activation of neutrophils following 
bacterial infection (13).  IL-17A indirectly stimulates recruitment of neutrophils into the 
airways via the induction of C-X-C chemokines (12-17). Production of IL-17A was first 
reported in CD4
+
 cells (27).  IL-17A-producing Th17 cells are regarded as a distinct 
subset of T cells, divergent from Th1 and Th2 cells.  It is now established that 
neutrophils, eosinophils and macrophages also produce IL-17A (15, 28, 29).   It was 
recently shown that IL-13 signaling inhibits IL-17A production from CD4
+
 Th17 cells 
(30).  Thus, it is likely that, in our study, IL-17A production was derepressed in IL-4R 
KO mice deficient in IL-13 signaling.  Further, we found that, in the absence of IL-4R 
signaling, BAL macrophages from OVA-treated mice were polarized to produce IL-17A 
as well as type 1 cytokines.  Macrophage IL-17A production likely contributed to the 
observed neutrophilic inflammation.   
We found that OVA-treated IL-4R KO mice showed neutrophilic airway 
inflammation, essentially constituting a model of allergic, type 1 cytokine-driven 
neutrophilic asthma.  Although the allergic type 2 immune response has been considered 
as a hallmark of asthma, only 50% of asthma cases are due to eosinophilic inflammation, 
the rest showing airway neutrophils (31).  This type of asthma has been associated with 
specific asthma phenotypes including severe asthma, corticosteroid-resistant asthma, 
nocturnal asthma and occupational asthma (32-40). Although non-allergic stimuli, for 
example, lipopolysaccharide and ozone (41-43), have been associated with neutrophilic 
airway inflammation, our data are consistent with the notion that a subset of allergic 
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patients may experience neutrophilic rather than eosinophilic airway inflammation due to 
the influence of type 1 cytokines and IL-17A.     
In conclusion, we showed that IL-4R KO mice sensitized and challenged with 
OVA have significant neutrophilic inflammation which is further enhanced by RV 
infection.  Macrophages from OVA-treated IL-4R KO mice showed an M1 polarization 
pattern and expressed type 1 cytokines and IL-17 in response to RV infection.  We 
conclude that, in mice with allergic airways disease, the macrophage activation state 
determine the response to RV infection. 
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     Chapter 5 
        
 
 
 
  Summary, Limitations, and Future Directions  
 
Summary 
Asthma, the most common chronic illness in Westernized countries, is 
characterized by recurrent attacks of airflow obstruction, airway inflammation and 
airways hyperresponsiveness (AHR) (1, 2).  Airway changes in asthma have been linked 
to allergy and type 2 immune responses. However, the mechanisms of asthma 
development are not fully understood. Recent studies indicate that early-life respiratory 
viral infection is a major predisposing factor for subsequent asthma development (3). In 
high risk infants, wheezing-associated illness with rhinovirus (RV) is the most significant 
risk factor for asthma development, more so than allergen sensitization or infection with 
respiratory syncytial virus (RSV) (4, 5).  In hospitalized infants, RV infection was also 
associated with asthma development, in contrast to RSV which was negatively associated 
(6). Thus, with the appropriate genetic background and allergen exposure, RV infection 
in early life may modulate the immune response, increasing the likelihood of asthma 
development. Alternatively, RV may simply reveal a pre-existing tendency for asthma (7, 
8).  An improved understanding of immune responses to RV in early life is needed to 
resolve this issue. 
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Recent studies have found that neonatal immunity is qualitatively different from 
that of adult.  Neonatal animals are refractory to Th-1 responses and permissive to 
allergic Th2 responses (9, 10). It is therefore possible that early life RV infection 
promotes allergic asthma by augmenting or maintaining this response. Previously, to test 
this, we infected 7 day-old BALB/c mice with RV. In contrast to adults, neonatal 
infection induced airway hyperresponsiveness and mucous metaplasia in lungs. These 
physiological changes were dependent on IL-13, a canonical type 2 cytokine (11). 
Neonatal mice developed sustained airways hyperresponsiveness and mucous cell 
metaplasia. Neonatal RV infection also induced IL-13 production by invariant natural 
killer T cells (iNKT) cells, as well as lung infiltration by CD11b+ monocytes.  
In this research, we hypothesized that neonatal RV infection induces type 2 
cytokine production by innate immune cells, leading to mucous metaplasia and airways 
hyperresponsiveness. To study the developmental and immunologic mechanisms of RV-
induced chronic airways disease, I intended to assess the role of TSLP and and IL-25, 
epithelial cytokines which play a role in the maturation and activation of Th2 (12-17) and 
iNKT cells (18, 19).  TSLP and IL-25 also induce type 2 (Th2-like) cytokine production 
by type 2 innate lymphoid cells (ILC2s) (20-26).  
Six day-old BALB/c mice and TSLPR KO mice as well as eight week-old 
BALB/c mice were inoculated with sham HeLa cell lysate or RV.  Airway responses 
from 1 to 28 days after infection were assessed by qPCR, ELISA, histology, 
immunofluorescence microscopy, flow cytometry and methacholine responsiveness. 
Selected mice were treated with a neutralizing antibody to IL-25.  
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Compared to mature mice, RV infection of neonatal mice increased expression of 
the type 2 cytokines IL-13, IL-4 and IL-5. In contrast, the induction of type 1 cytokines 
IFN-, IL-12p40 and TNF-α gene was blunted in neonatal mice, whereas expression was 
increased in mature mice. Consistent with the attenuated type 1 response, viral replication 
and load tended to be greater 3-7 days after inoculation in neonatal mice compared to 
adults. Neonatal RV infection led to persistent asthma-like pathophysiological changes 
including IL-13 expression, mucous metaplasia and airways hyperresponsiveness. RV 
infection leads to the induction of IL-25 mRNA and protein in neonatal mice but not in 
mature mice. Additional studies examining the age-dependency of RV-induced IL-25 
expression showed significant induction only in mice younger than 6 days-old. Lung 
immunofluorescent staining showed that RV-infected epithelial cells were the major 
source of IL-25. Flow cytometric analysis found that RV infection of neonatal but not 
mature mice expands the population of IL-17RB-expressing ILC2s. These cells were the 
major population secreting IL-13 in RV-infected neonatal mice. Neutralization antibody 
of IL-25 treatment in RV-infected neonates strongly inhibited  ILC2 expansion, mucous 
hypersecretion and airways responsiveness. These findings suggest that early-life viral 
infection could contribute to asthma development by provoking age-dependent, IL-25-
driven type 2 immune responses. 
 To test the role of TSLP, we infected neonatal BALB/c mice and TSLPR KO 
mice. RV infection increased TSLP protein abundance after early-life RV infection while 
reducing TSLP mRNA and protein expression in mature mice. We also found that TSLP 
mRNA was decreased with RV infection in the mice age 8 days or older.  Induction of 
TSLP protein expression was present only in mice ≤  6 days of age. RV infection 
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increased TSLP staining in the airways epithelium of neonatal mice, which may have 
infected with RV as well. Neonatal RV infection induced persistent mucus hyperplasia 
and airway hyperresponsiveness in wild type mice whereas the phenotype was blocked in 
TSLPR KO mice.  Expansion of type 2 innate lymphoid cells (ILC2s) following neonatal 
RV infection was also significantly inhibited in TSLPR KO mice. Finally, when 
combined with IL-25 and IL-33, TSLP had a direct synergistic effect on ILC2 GATA3, 
IL-13, IL-5, ST2L and IL-17RB mRNA expression. These results show that TSLP plays 
a necessary role in the development of mucous metaplasia, airways hyperresponsiveness 
and ILC2 expansion in RV-infected immature mice.   
  We conclude that TSLP and IL-25 are required for persistent mucus metaplasia 
and airway hyperresponsiveness as well as ILC2 expansion with neonatal RV infection. 
Induction of type 2 cytokines, including IL-13, IL-25, and TSLP, in response to viral 
infection was developmentally regulated.  These findings may suggest, with an 
appropriate genetic background, early-life RV infection may modulate and induce type 2 
immune response, thereby leading to the development of persistent mucus metaplasia and 
airway hyperresponsiveness. Further characterization of this immune pathway may lead 
to new molecular and cellular targets for the prevention of asthma.  
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Figure 5-1. Proposed mechanism for neonatal RV-induced mucus metaplasia and 
airway hyperresponsiveness. 
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Limitations and Future directions 
Mouse model of RV infection 
 We have successfully established a mouse model of RV infection and utilized the 
model to test the effect of RV in the context of respiratory disease and inflammation. We 
infected C57BL/6 mice with minor groups serotype RV1B and shown increased CXC 
chemokines, elevated neutrophils, and moderate changes in airway hyperreactivity (27). 
We understand the possibility of slightly different lung pathology between minor group 
RV and major group RV, for minor group RV binds to LDL-R compared to major group 
viruses including RV16 and RV39 which bind to the receptor to ICAM-1 (28).   However, 
sequence analysis of RV serotypes (29) and studies in RV-infected cultured cells (30) and 
mice (31) suggest that  , as well as sequence analysis suggest that the distinction between 
at least some major and minor group strains may not be clinically relevant. 
We would like to add a few additional caveats about our mouse model of RV 
infection.  We (27) and others (31) have found that a much higher viral inoculum is 
required to infect mice compared with humans. This finding is to be expected, because 
differences in the homology of viral receptors and intracellular signaling mechanisms are 
likely to restrict viral infection and replication in mice.  Nevertheless, we have clearly 
shown that human RV1B replicates in mouse lungs, as evidenced by: 1) the presence of 
negative-strand viral RNA in the lungs of inoculated mice, 2) transmissibility of RV 
infection from the lung homogenates of inoculated mice to cultured HeLa cells; and 3) 
the induction of a robust lung interferon response (27).  Also, despite a low viral titer, RV 
was associated with a significant ILC2 response.  These data are consistent with recent 
speculation by workers in the field that relatively innocuous RV infections in early 
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childhood lead to sustained changes in the immune response which contribute to the 
development of asthma.    
 
Interaction with other risk factors for asthma development 
We recognize that asthma is a complex disease, and the effects of RV infection in 
early infancy are likely to be determined by interplay with genetic and environmental 
factors (allergen exposure, microbiome, viral re-infection).  For example, a positive 
family history of asthma is a known risk factor for asthma development, and it has 
recently been found that infants of mothers with asthma are more likely to have severe 
respiratory tract infections with RV (8). Variants at the 17q21 locus were recently 
associated with asthma in children who had had RV-induced wheezing illnesses (32).  In 
preliminary studies, we have found that C57BL/6 mice are less sensitive to RV infection 
than BALB/c mice.  In addition, we have shown that early-life RV infection augments the 
effect to subsequent allergen exposure (33), and it has been speculated that viral infection 
may lead to atopic disease and asthma exacerbations via the production of virus-specific 
IgE (34).  With regard to microbiome, detection of pathogenic bacteria during RV 
infections is associated with exacerbations (35), suggesting the importance of airway 
bacteria in the response to RV.  In addition, early-life antibiotic treatment increases the 
response to ovalbumin in mature mice (36), and lung microbiota promote tolerance in 
immature mice exposed to house dust mite allergen (37). Finally, the timing of viral 
infection may play a role, with earlier infections increasing the risk of persistent airway 
responses.   
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Unfortunately, it is impossible to explore all these factors in a single thesis 
research. Therefore, we have chosen to focus the roles of innate cytokines and ILC2s in 
the response to early-life viral infection.  Nevertheless, for future direction, it is plausible 
to test the effects of genetic background and microbiome with the following simple 
experiments.  First, experiments examining the differential response to RV1B infection in 
immature BALB/c and C57BL/6 mice can be performed.  If clear differences are found 
between the two strains, F2 progeny can be produced with cross breeding, infect the 
progeny with RV, phenotype the mice, and identify candidate genes regulating the RV 
response using quantitative trait locus (QTL) mapping.  High-resolution SNP panels are 
widely available for this purpose (38).  Second, germ-free and antibiotic-treated BALB/c 
and C57BL/6 immature mice can be infected with RV1B, anticipating that these mice 
will have exaggerated type 2 responses to RV infection compared to their SPF-pathogen 
free counterparts.   
 
Recurrent heterologous infection and ILC2s 
In our original report, we found that immature mice infected with RV on day 7 of 
life showed mucous metaplasia at 35 days of life (33).  However, by 60 and 100 d after 
early-life RV infection, mucous metaplasia had mostly resolved.  These data are 
consistent with studies showing that RSV was an independent risk factor for the 
subsequent development of wheezing up to age 11 years, but not at age 13 (39).  
Nevertheless, under certain circumstances, early life infection might induce long-term 
effects. It is therefore conceivable that early life RV infection alters the immune response 
to future viral infections, leading to type 2 rather than type 1 responses, and that these 
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responses are driven in part by ILC2s.  
RV is the most common respiratory tract infection in infants, comprising up to 
80% of all infections (40).  Virtually all children are infected with RV during infancy.  
Longitudinal surveillance of RV infections by PCR has shown that pre-school age 
children have about six distinct RV infections per year  (41).   Given the large number of 
known RV serotypes (which do not include the new HRV-C lineage), it is almost certain 
that most children experience infections with many different RV strains.  Naturally-
acquired RV infections do not produce non-specific immunity to reinfection of the 
respiratory tract by heterologous serotypes, even if the viruses are from the same group, 
for example RV1A and RV2 (42, 43).  Perhaps the second most common respiratory 
infection in infants is RSV.  RSV isolates can be divided into 2 groups, A and B, which 
are distinct at the antigenic level. In addition, RSV groups can be subdivided into several 
strains or genotypes that co-circulate during epidemics.  Immunity following primary 
exposure does not prevent subsequent infections (44). 
While human studies have demonstrated the strong association between viral 
infections and asthma development (4, 5), few animal studies have examined the effects 
of reinfection with RV or RSV in an animal model.  A recent study (45) using an RV1B 
mouse model similar to our own showed that multiple homologous infections were 
required to generate neutralizing antibodies.  No inflammatory responses were assessed. 
With RSV, infection of immature mice predisposes to the development of IL-13-
dependent airway eosinophilia and hyperresponsiveness after homologous reinfection, 
whereas infection at a later age protects against reinfection (46, 47): Early-life RSV 
infection combined with homologous reinfection five weeks later resulted in enhanced 
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airways responsiveness, airway eosinophilia and increased IL-13 levels after reinfection.  
Both CD4- and CD8-positive T cells were a source of IL-13 in the lung.  In contrast, 
infection of mice at weaning elicited a protective airway response upon reinfection which 
was characterized by increased airway inflammation but without the development of 
airway hyperresponsiveness or eosinophilia, and decreased IL-13 levels.  These data are 
consistent with the notion that early-life RSV infection polarizes the adaptive immune 
response in such a way that homologous reinfection stimulates type 2 immune responses. 
The situation with heterologous infections is likely to be different from that 
described above.  Infection with distinct antigenic strains is less likely to promote a T 
cell-mediated memory response.  An alternative mechanism by which organisms lacking 
adaptive immune responses – for example, plants, invertebrates and newborn animals -- 
are protected against reinfection with pathogens has been referred to as “trained 
immunity.”  In trained immunity, secondary infections induce a non-specific heightened 
activation state without the involvement of a T and B cell adaptive immune response 
(48).  Due to limited antigen exposure and distinct adaptive immune function compared 
to the adult, the newborn animal has a significant dependence on innate immune function 
for host defense to microbial challenge (49).  The mechanisms that mediate the 
heightened activation state of trained immunity may involve innate immune cells such as 
ILCs, macrophages and NK cells, as well as improved pathogen recognition by pattern 
recognition receptors. 
Considering ILCs, there are a number of mechanisms by which ILC2s may drive 
the response to secondary infection.  First, there could be a second expansion of ILC2s.  
Although developing mice “switch off” IL-25 production by 8 days after birth (50), ILC2 
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expansion could be stimulated by epithelial-derived TSLP or IL-33. Cysteinyl 
leukotrienes have recently been shown to promote Alternaria species-induced ILC2 
accumulation and cytokine expression in vivo and ex vivo (51), and experimental RV 
infections double BAL cysteinyl leukotriene levels in adult volunteers (52).  Second, 
heterotypic infection could elicit cytokine production from ILC2s which expanded after 
the first infection.  We have shown that these cells persist in immature mouse lungs at 
least three weeks after initial infection (50), and other studies suggest even longer 
persistence (53). Thus it is even possible that secondary RV infection could directly elicit 
IL-13 production from ILC2s which persist in the lung after the original infection. 
 
Potential role of IL-33 
IL-33 is a pro-allergic cytokine that belongs to the IL-1 superfamily. It is 
predominantly released at the epithelial barrier when it is exposed to allergens, pathogens 
or injury-inducing stimuli. After secretion, IL-33 binds to a ST2L, which activate 
signaling pathway for type 2 cytokines and chemokines via MyD88, TRAF6, IRAK-1/4 
and MAP kinases (54). Similar to IL-1β and IL-18, other cytokines in IL-1 superfamily, 
IL-33 lacks an apparent signal peptide for secretion. Therefore, IL-33 was first thought to 
be synthesized as an inactive precursor and get liberated as an active cytokine by caspase-
1 (54). However, recent studies found that full-length IL-33 is biologically active, and IL-
33 cleavage by caspases dramatically inactivates IL-33 function (55, 56). Thus, it has 
been suggested that full-length IL-33 is released from necrotic cells as danger-associated 
molecular pattern (DAMP) or an “alarmin” to induce type 2 immunity, whereas IL-33 is 
inactivated during apoptosis by caspase activity (57).  
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In chapter 2, we showed that IL-33 mRNA expression is not increased with RV 
infection neither in neonates nor in adults. However, considering the fact that full-length 
IL-33 can released during necrosis, it is conceivable that RV infection may increase lung 
IL-33 secretion. In our pilot study, we found that RV infection increases IL-33 protein 
level in neonates but not in adults, while there was no obvious difference in mRNA 
expression of IL-33 (data not shown). The role of IL-33 will be tested by using 
neutralizing antibody of IL-33 in BALB/c neonates in future. 
 
Potential role of IFN-γ in regulation of IL-25 and TSLP 
 In chapter 2 and chapter 3, we have found the age-dependency of IL-25 and TSLP 
increase with RV infection. Induction of IL-25 and TSLP was only observed in the mice 
younger than day 6 of age with RV infection. Considering the epigenetic modification 
favoring type 2 cytokine induction in T cells (58), it is possible that the regulatory regions 
of IL-25 and TSLP are also epigenetically favored transcription in neonates compared to 
adults.  
Alternatively, blunted induction of type 1 cytokine IFN- in RV-infected neonates 
could be permissive for IL-25 and TSLP induction. We and others showed that immature 
animals are more susceptible to viral infection, in part due to impaired IL-12 and IFN 
production (59-62). As shown previously with neonatal adenovirus infection (63), baby 
mice showed impaired IFN-γ responses to RV1B infection compared to adults, as well as 
reduced levels of IL-12 and TNF-α.  We found that RV-infected immature 6 day-old 
mice maintained high levels of viral RNA ≥ 72 h after infection, representing at least 
three rounds of viral replication, in contrast to mature mice in which vRNA and titer peak 
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within 24 h after infection (64).  IFN-γ has been shown to inhibit double-stranded RNA-
induced TSLP production in fibroblasts (65) and keratinocytes (66).  Thus, immature 
animals with relatively impaired IFN responses would be expected to express higher 
levels of TSLP in response to viral infection. Moreover, in NK cell-deficient mice, RSV 
infection leads to an exaggerated IL-25 response which is blocked by recombinant IFN- 
treatment. This result suggests the potential role of IFN-γ  in blocking IL-25 expression 
(12). In a pilot study, we found that recombinant IFN-γ treatment reduces the RV-
stimulated TSLP level in vitro and in vivo (data not shown). We also found that 
recombinant IFN-γ inhibited the development of mucus hyperplasia and airway 
hyperresponsiveness in neonatal mice (data not shown). Moreover, recombinant IFN-γ 
strongly blocked the activation of ILC2s (data not shown). In future, the role of IFN-γ in 
regulation of IL-25 and TSLP could be tested.  
 
Physiological Relevance 
 In high risk infants, wheezing-associated illness with rhinovirus (RV) is the most 
significant risk factor for asthma development, more so than allergen sensitization or 
infection with respiratory syncytial virus (RSV)(4, 5).  In hospitalized infants, RV 
infection was also associated with asthma development, in contrast to RSV which was 
negatively associated (6), Thus, with the appropriate genetic background and allergen 
exposure, RV infection in early life may modulate the immune response, increasing the 
likelihood of asthma development. 
 In this current study, we found that infection of neonatal but not adult mice with 
human rhinovirus (RV) induces mucous metaplasia and airways hyperresponsiveness 
 135 
which is associated with enhanced expression of IL-13, IL-25 and TSLP, reduced 
expression of IFN-γ, IL-12p40 and TNF-α, and expansion of ILC2s. These findings 
suggest that early-life viral infection could contribute to asthma development by 
provoking age-dependent, IL-25- and TSLP-driven type 2 immune responses.  
 In spite of our findings in mice, situation in human may not be simple because of 
the complex etiology of asthma. In human, the effects of RV infection in early infancy 
are likely to be determined by interaction with genetic factors (family history of atopic 
diseases), and environmental factors (allergen exposure, microbiome, viral re-infection).  
Also, the timing of viral infection may play a role, with earlier infections increasing the 
risk of persistent airway responses. More clinical research studying the interplay between 
neonatal RV infection and other etiological factors of asthma, in the context of IL-25 and 
TSLP response, may be required to determine precise role of early-life RV infection in 
the development of asthma in human. Completion of this future work, which would 
include a new model of neonatal infection and human studies, will address the novel 
hypothesis that, in susceptible individuals, early viral infection contributes to asthma 
development.    
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